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Abstract
The textile industry sector has shown a growing interest in the functionalization of conventional
fabrics to produce innovative products that enhance health, safety and ergonomics. This research
is concerned with developing a functional fabric with durable antibacterial and fragrant
properties by employing green chemistry materials and processes. This was achieved by
microencapsulation of aroma compounds in biodegradable polymers by the complex
coacervation method. Afterwards, the produced microcapsules were covalently attached to cotton
fabrics by means of thermofixation grafting process using a polycarboxylic acid. The effects of
different processing parameters, including the type and amount of the emulsifier, the type and
amount of the hardening agent, and the wall to core ratio, on the morphology, size, dispersion,
encapsulation efficiencies (EE%) of the produced microcapsules were examined. The release
profiles of the active agents were investigated. The impact of different grafting conditions on the
microcapsules adhesion was inspected. Scanning electron microscopy (SEM) and Fourier
Transform Infrared (FTIR) spectroscopy confirmed the adhesion of the produced microcapsules
on the cotton fabrics. The antibacterial assays of both the produced microcapsules and the
functionalized fabrics demonstrated that they exhibited a sustained antibacterial activity.
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Chapter 1: Introduction
1.1.

Relevance and motivation

The increase in the market competitiveness along with the diversity of consumers’ demands has
created a challenging environment in the textile industry sector. This subsequently led to the
production of innovative textile products with new properties that enhance ergonomics, health
and safety.1 Functional textiles are one of those novel products in the textile area. They are
obtained by either incorporating active ingredients to conventional fabrics, such as cotton, wool,
silk or polyester, or by manufacturing new materials (e.g., nanofibers and nanocomposites).2,3
Innovative technologies in textiles have succeeded in offering a wide variety of fabrics with
unprecedented functions. The most common applications of functional textiles include phase
change materials, insect repellents, antimicrobials, fragrances, dyes and colorants, skin softeners
and moisturizers, some medicines, and flame retardants.2,4-8
Enhancing the durability and prolonging the lifetime of functional textiles have been always one
of the most challenging missions for the manufacturers of these types of textiles. This is due to
the fact that these textiles are non-disposable and need to be washed after use.
Microencapsulation techniques have been known to provide textiles with long-lasting properties
and added value.9,10 This process involves the coating of the active ingredient with one or more
polymeric materials to form microcapsules whose size range between 1µm and 1000µm. These
microcapsules when later fixed onto the fabrics, they create a product with new properties and
added value. In fact, each microcapsule acts as a minute reservoir for the active ingredient which
would be liberated under specific conditions, such as pH, mechanical factors, temperature or
diffusion.11 Therefore, the process of microencapsulation allows the controlled release of the
active substances and their protection against the surrounding environmental conditions, such as
heat, oxygen, and light.1,2 This process thus, remarkably increases the durability and long
lastingness of the effect of the functional ingredient incorporated onto these textiles.
Nowadays, researchers and manufacturers are increasingly interested in green chemistry
protocols, taking into account the growing public concern and awareness of the importance of
the utilization and application of safe and eco-friendly materials and processes. However, the
majority of the commercially available microcapsules that are intended for textile applications
1

are made of melamine-formaldehyde, urea-formaldehyde or phenol-formaldehyde resins.12,13
Regardless of the fact that these polymers are used because of their good thermal stabilities and
their ability to be modified according to the desired release profiles, they represent a serious
threat for the environment and human health. This is due to their being non-recyclable
thermosetting polymers, and also due to the carcinogenicity and toxicity of formaldehyde.14,15
Thus, the replacement of such resins with safe and environmentally benign materials has become
extremely important.16 Biocompatible and biodegradable polymers, such as alginate, gum
Arabic, gelatin, chitosan, and cyclodextrins, have recently become promising alternatives for the
previously mentioned toxic polymers; as they are known to be eco-friendly, abundant, and safe
to human health.17
Fabrics of natural origins, such as cotton are known to be more susceptible to colonization by
invasive microbes than synthetic ones.16 This is due to their high hydrophilic and porous
composition that tends to retain humidity, nutrients, and oxygen, which is indeed considered as
an ideal environment for the growth of high number of microorganisms.16,18 Consequently, these
microorganisms result in unpleasant odors, transmission of diseases and allergic responses in
some individuals. Additionally, they cause the deterioration of fabrics in terms of color
degradation, loss of elasticity and tensile strength, and interference with the dyeing and printing
processes.16,19 Hence, it is crucial to combat these undesired effects through imparting
antimicrobial additives to textiles.

1.2.

Statement of purpose

This study aims to confer antimicrobial and fragrant properties to cotton fabrics by means of
microencapsulation, depending on green and eco-friendly materials, and thus contribute to the
ongoing advancements in the fields of both microencapsulation and functional textiles.
The main investigations that were conducted in this thesis are as follows:
The preparation of the microcapsules and formulation optimization was achieved by means of
the complex coacervation microencapsulation method; using chitosan and gum Arabic as shell
materials. Vanillin and limonene were incorporated independently as core (active) materials. The
influence of using different process parameters (e.g., type and amount of emulsifier and type of
hardening agent) was studied to optimize the final formulation of the microcapsules. This was
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followed by the characterization of the prepared microcapsules through the analysis of the
morphology, particle size distribution and encapsulation efficiency of the prepared
microcapsules. The release of active agents was also investigated through release profiles of both
limonene and vanillin microcapsules employing GC-FID. The grafting of the microcapsules to
cotton fabrics was done by the pad-dry-cure method using citric acid as a cross-linker. SEM was
used to examine the treated fabrics before and after washing and FTIR spectroscopy was used to
confirm the covalent attachment of the produced microcapsules to the cotton fabrics. Finally,
antimicrobial assays were conducted to examine the antibacterial activities of the produced
vanillin and limonene microcapsules. These were evaluated using the Agar Diffusion Method,
whereas the antibacterial activity of the treated fabrics was assessed by the Standard Test Method
under Dynamic Contact Conditions (American Society for Testing & Materials, ASTM Standard
E 2149-01).
To the best of our knowledge, no reports previously investigated the microencapsulation of
vanillin powder by the complex coacervation microencapsulation technique. Furthermore,
limonene encapsulation using chitosan and gum Arabic as a complex coacervation pair was not
previously reported in the literature.

1.3. References
1. Holme, I. Innovative technologies for high performance textiles. Coloration Technology 2007,
123, 59-73.
2. Nelson, G. Application of microencapsulation in textiles. Int. J. Pharm. 2002, 242, 55-62.
3. Carfagna, C.; Persico, P. Functional Textiles Based on Polymer Composites. Macromolecular
Symposia 2006, 245, 355-362.
4. Specos, M. M. M.; García, J. J.; Tornesello, J.; Marino, P.; Vecchia, M. D.; Tesoriero, M. V.
D.; Hermida, L. G. Microencapsulated citronella oil for mosquito repellent finishing of cotton
textiles. Trans. R. Soc. Trop. Med. Hyg. 2010, 104, 653-658.
5. Rodrigues, S. N.; Martins, I. M.; Fernandes, I. P.; Gomes, P. B.; Mata, V. G.; Barreiro, M. F.;
Rodrigues, A. E. Scentfashion ®: Microencapsulated perfumes for textile application. Chem.
Eng. J. 2009, 149, 463-472.
6. Ma, Z.; Yu, D.; Branford-White, C.; Nie, H.; Fan, Z.; Zhu, L. Microencapsulation of
tamoxifen: Application to cotton fabric. Colloids and Surfaces B: Biointerfaces 2009, 69, 85-90.
3

7. Flambard, X.; Bourbigot, S.; Kozlowski, R.; Muzyczek, M.; Mieleniak, B.; Ferreira, M.;
Vermeulen, B.; Poutch, F. Progress in safety, flame retardant textiles and flexible fire barriers for
seats in transportation. Polym. Degrad. Stab. 2005, 88, 98-105.
8. Son, K.; Yoo, D. I.; Shin, Y. Fixation of vitamin E microcapsules on dyed cotton fabrics.
Chem. Eng. J. 2014, 239, 284-289.
9. Hassan, M. M.; Sunderland, M. Antimicrobial and insect-resist wool fabrics by coating with
microencapsulated antimicrobial and insect-resist agents. Progress in Organic Coatings 2015,
85, 221-229.
10. Bonet Aracil, M.; Monllor, P.; Capablanca, L.; Gisbert, J.; Díaz, P.; Montava, I. A
comparison between padding and bath exhaustion to apply microcapsules onto cotton. Cellulose
2015, 22, 2117-2127.
11. Martins, I. M. Microencapsulation of Thyme Oil by Coacervation: Production,
Characterization and Release Evaluation. University of Porto, Portugal, 2012.
12. Junfeng Su, L.; Wang, L.; Ren, L. Fabrication and thermal properties of microPCMs: Used
melamine‐ formaldehyde resin as shell material. J Appl Polym Sci 2006, 101, 1522-1528.
13. Salaün, F.; Lewandowski, M.; Vroman, I.; Bedek, G.; Bourbigot, S. Development and
characterisation of flame- retardant fibres from isotactic polypropylene melt- compounded with
melamine- formaldehyde microcapsules. Polym. Degrad. Stab. 2011, 96, 131-143.
14. Coggon, D.; Ntani, G.; Harris, E. C.; Palmer, K. T. Upper Airway Cancer, Myeloid
Leukemia, and Other Cancers in a Cohort of British Chemical Workers Exposed to
Formaldehyde. Am. J. Epidemiol. 2014, 179, 1301-1311.
15. Cogliano, V. J.; Grosse, Y.; Baan, R. A.; Straif, K.; Secretan, M. B.; El Ghissassi, F. Meeting
Report: Summary of IARC Monographs on Formaldehyde, 2- Butoxyethanol, and 1- tertButoxy- 2- Propanol. Environ. Health Perspect. 2005, 113, 1205-1208.
16. Hebeish, A.; Abdel-Mohdy, F.; Fouda, M. M. G.; Elsaid, Z.; Essam, S.; Tammam, G. H.;
Drees, E. A. Green synthesis of easy care and antimicrobial cotton fabrics. Carbohydr. Polym.
2011, 86, 1684-1691.
17. Shahid-ul-islam, M.; Shahid, F.; Mohammad, F. Green Chemistry Approaches to Develop
Antimicrobial Textiles Based on Sustainable Biopolymers—A Review. Ind Eng Chem Res 2013,
52, 5245-5260.
18. Hebeish, A.; El-Naggar, M.; Fouda, M. M. G.; Ramadan, M. A.; Al-Deyab, S.; El-Rafie, M.
Highly effective antibacterial textiles containing green synthesized silver nanoparticles.
Carbohydr. Polym. 2011, 86, 936-940.

4

19. Joshi, M.; Ali, S. W.; Purwar, R.; Rajendran, S. Ecofriendly antimicrobial finishing of
textiles using bioactive agents based on natural products. . Indian Journal of Fibre and Textile
Research 2009, 34, 295-304.

5

Chapter 2: State of the Art
2.1. Microencapsulation: Definition and Purpose
Microencapsulation involves the entrapment of solid, liquid or gaseous materials in small
particles that release their contents at a controlled rate over a prolonged period of time and under
certain conditions.1,2 These particles are called microcapsules. The word “encapsulate” is derived
from the Latin words; “en” which means in and “capsula” which means a small box. Thus, the
overall meaning of to encapsulate is to place something in a box.3 Microcapsules have a diameter
of 1-1000 µm.4-6 They are made up of a core (inner part) which contains the active material, and
a wall material (outer part) that surrounds the core and creates a physical barrier around it.2 The
core is also called the nucleus, payload phase, fill or internal phase; whereas the wall material is
sometimes called the shell, encapsulant, carrier or external phase.4,7 The core material can be in
the form of solid, liquid, or gas. The morphological structure of microcapsules depends on
different parameters, e.g., the type of the shell material, its rigidity, and the preparation method
used. The shape of the microcapsule may range from being spherical, irregular, with one core or
multicores, with single coating or coatings that consist of more than one layer.
Microencapsulation protects the active agent from different adverse conditions in the
surrounding environment, such as humidity, air, heat, light and exposure to changes in pH.
Additionally, it guards against the rapid evaporation of highly volatile active agents and helps in
controlling the rate of their release.6

2.2 Microencapsulation Techniques
There are different techniques used for the preparation of microcapsules. They can be classified
into three main categories being the chemical methods, the physico-chemical methods, and the
physico-mechanical methods.
2.2.1. Microencapsulation by Chemical methods


In situ polymerization

In this method the wall material of the microcapsule is chemically produced due to the
polymerization of monomers added to an emulsion that is formed of a dispersed core material
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and a continuous phase. Subsequently, polymerization starts to occur at the interface between the
continuous phase and the immiscible core material, on the continuous phase side. In the
beginning of the process, a prepolymer of low molecular weight is formed then it grows with
time and deposits on the interface between the continuous phase and core material creating a
solid shell.8 In this method no reagents are added to the core material and the polymerization
occurs exclusively in the continuous phase.9


Interfacial polymerization

In interfacial polymerization, the shell of the capsule is formed on the surface of a core droplet as
a result of the polymerization of reactive monomers. Two sets of monomers that are able to react
with each other are used. This method basically involves the formation of an emulsion of two
immiscible phases, where one of the monomers is solubilized in the core material and a comonomer is added to the continuous phase. The reaction conditions are then set to promote the
polymerization and the wall formation at the interface.10
The most commonly used monomers are the multifunctional isocyanates and acid chlorides.8 The
reaction of isocyanate with an amine results in the formation of a polyurea shell, whereas the
reaction of acid chloride with an amine results in the formation of a polyamide or a polynylon
microcapsule shell. Polyurethane shell materials are obtained by the reaction of isocyanate with a
hydroxyl containing monomer. Both liquid and solid core materials can be encapsulated by this
method. 8,9
2.2.2. Microencapsulation by Physico-mechanical methods


Spray drying

Spray drying involves the atomization of a solution or suspension of the active agent and the
coating material into a heated drying gas which causes the water to evaporate rapidly, leaving
dried microcapsules. The microcapsules are then obtained by continuous discharge from a
collecting chamber in the spray dryer.5,8 The initial temperature of the air is usually 150-220°C
which allows evaporation to occur quickly, then it decreases to be within the typical range of 5080°C.11 The spray drying technique is suitable for the encapsulation of labile and thermally
sensitive substances due to the short exposure time to heat, which typically does not exceed few
seconds.11,12 This method produces small microcapsules in the form of very fine powder (10-50
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µm) or large particles that are 2-3 mm in diameter.11 Spray drying is considered the most popular
microencapsulation technique used in food industry.13 It has the advantage of being economic,
rapid and efficient. However, this method has the disadvantage of requiring a coating agent that
should be soluble in water to a certain extent. The use of shell materials with low water solubility
(e.g., sodium caseinate, whey protein, carboxymethyl cellulose, and guar gum) makes the
process expensive due to the need of increasing the amount of water used, and thus requiring
more time for its evaporation.11


Spray chilling

Spray chilling involves the loading of the core material into a warm bath of the wall material
followed by spraying through a heated nozzle allowing the shell to solidify and form the
microcapsules. Spray chilling is carried out by equipment similar to the one used in spray drying
but the air used is not heated.5


Solvent evaporation/extraction

Microencapsulation by solvent evaporation is carried out through four main steps: (1) dissolution
of the active core in an organic solvent that contains the polymeric shell material; (2)
emulsification of the organic (dispersed) phase in an aqueous (continuous) phase; (3) extraction
of the solvent from the dispersed phase by the continuous phase, and evaporation of the solvent
from the organic phase by heating; which causes the coating material to shrink around and
encapsulate the core agent; (4) recovery and harvesting of the formed microcapsules.8,14,15 The
solvent evaporation technique is most commonly applied in the pharmaceutical industry because
it provides a controlled release profile of drugs.15


Air suspension coating

The air suspension technique involves suspending solid core particles in a chamber supported
with an upward flowing air stream, and spraying of the coating material onto the suspended
particles.8,12 The air stream carries the particles in a repetitive circulating pattern to the coating
zone in the chamber, where a polymeric coating material is being sprayed to the moving
particles. The number of the cycles applied depends on the desired thickness of the wall
material.9,12 The coating material used can be in the form of aqueous or solvent solution,
emulsion, suspension or hot melt. The supporting air stream aids in the solidification of the
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coating and drying of the produced microcapsules.12 This technique is used to encapsulate solid
cores, such as granules, crystals and powders. This technique however cannot be used to coat
liquid droplets unless they are first absorbed on a porous solid.9


Pan coating

The pan coating technique is one of the oldest methods used in the pharmaceutical industry to
produce coated particles and tablets. The solid cores are initially tumbled in a rotating pan-like
container in which the coating material is slowly applied in the form of solution or atomized
spray. The solvent is then removed through passing warm air over the produced coated particles,
or by means of drying oven.12 The method is also used in microencapsulation to produce
microparticles of size greater than 600 µm, usually for controlled-release purposes.16,17


Centrifugal extrusion

The centrifugal extrusion technique is used to encapsulate liquid cores. It involves the usage of a
rotating extrusion head with concentric nozzles. The core material is pumped through a central
tube and the wall material in a liquid form is pumped through a surrounding circular space.9,12
Consequently, the coating material comes out at the end of the nozzle forming a membrane that
surrounds the core material which flows out of the nozzle simultaneously causing the extrusion
of a liquid jet (Figure 2.1). This jet later breaks into droplets of the core material coated with the
wall material. Hardening of the droplets takes place later by allowing their passage into a heat
exchanger.

Figure 2.1 Schematic diagram of a centrifugal extrusion device with two-fluid nozzle. Adapted
from Ref. 9.
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The centrifugal extrusion method is known to form microcapsules of 400-2000 µm in size.9
Centrifugal extrusion can be applied for large scale production; since 22.5 kg of microcapsules
can be formed per hour using special nozzles, additionally, multiple-nozzle systems can be used,
e.g., heads of 16 nozzles are already available.12
2.2.3. Microencapsulation by Physico-chemical methods


Supercritical fluids assisted microencapsulation

This technique is considered environmentally friendly where supercritical fluids are used as
green solvents. Supercritical fluids are highly compressed gases, such as CO2, N2O, and alkanes
(C2 to C4), and are known to possess the properties of both gases and liquids in terms of viscosity
and diffusivity. Supercritical fluids are known as fluids kept at conditions above their critical
point. They have almost zero surface tension.18 Supercritical fluid technology is suitable for shell
materials that dissolve in supercritical fluids, and polymers that do not dissolve in them. In
practice, the process involves maintaining the core material and the shell material at high
pressure, followed by their release at atmospheric pressure through a nozzle. The quick drop in
pressure causes the desolvation of the shell and its deposition around the core agent.19
Microencapsulation using supercritical fluids provides the advantage of their high solvating
power, and hence the solubilization of the coating and core materials is fast and is done in the
absence of water.20


Coacervation

Coacervation is based on the separation of an initial homogenous polymer solution into two
phases: a polymer-rich phase (coacervate) and the other is almost polymer free and called the
equilibrium solution. The origin of the word coacervation is derived from the Latin word
“acervus” which means heap.8 Microencapsulation by coacervation provides controlled release
of the active agent and high encapsulation efficiency.20 Microencapsulation by coacervation is
divided into simple and complex coacervation. The former is carried out using a single polymer
as the shell material, while the latter occurs by the interaction of two oppositely charged
polymers.21
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i)

Simple Coacervation

Simple coacervation is induced by changing the pH or temperature, or the addition of inorganic
salts (e.g., sodium sulfate) in order to precipitate the initial solubilized wall material.20,22 Phase
separation and formation of coacervate of the polymeric wall material is followed by its
adsorption around the core material.23
ii)

Complex Coacervation

The complex coacervation technique is described in depth here since it is the microencapsulation
method used in this study. It is one of the important microencapsulation techniques due to its
high loading capacity, mild reaction conditions and controlled release possibilities.24,25 It is also
considered a green method that does not require the use of organic solvents.26 Complex
coacervation phenomenon was first reported in 1911 and was then studied more
comprehensively in the 40s in the light of the polymer system gelatin/gum Arabic. Nevertheless,
its use and application in the food industry only started in the 50s.27 More detailed and extensive
studies on the method have emerged during the last two decades. Figure 2.2 shows the number of
articles related to microencapsulation by coacervation in the period from 1995 to 2016. Complex
coacervation is defined as a fluid-fluid phase separation process that occurs as a result of
electrostatic attraction between two oppositely charged polymers. It may also involve hydrogen
bonding and hydrophobic interactions between the oppositely charged polymers.7

Figure 2.2 Number of scientific documents on microencapsulation/complex coacervation
published since 1995. (Obtained from Scopus database, February 2016; Search field:
microencapsulation complex coacervation; “in article title, abstract, and keywords”).
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Complex coacervation proceeds by mixing two polymer solutions with opposite charges, which
leads to their phase separation from the initial solution and subsequently their deposition around
an active core (Figure 2.3). The phase separation takes place by changing the pH or temperature,
or the addition of an electrolyte solution which results in the formation of coacervates that tend
to precipitate at the oil/water interface as a result of repulsion with the solvent.28,29 Consequently,
two phases are obtained; one is rich in the coacervate and is called the polymer-rich phase and
the other contains the solvent and is called solvent-rich phase.7

Figure 2.3 Schematic representation of complex coacervation method showing the formation of
coacervates between two oppositely charged polymers and their deposition at the core interface
creating the shell. Adapted from Ref. 29.
The classical and most extensively studied complex coacervation model is the gum Arabic
(negatively charged polyelectrolyte) and gelatin (positively charged polyelectrolyte).

This

system has received considerable attention in industrial applications. It has been used in the
manufacture of carbonless paper, fragrance strips and samplers, and flavor incorporation.30
However, gelatin is not always preferred due to its high viscosity and the new regulations that
restrict the use of some animal-derived proteins in some countries.24 Hence, other complex
coacervation pairs that exhibit new properties have emerged recently. These new systems are
based on proteins other than gelatin, and polysaccharides. The proteins are either of animal
origin, such as silk fibroin, albumin, and whey proteins, or of plant origin such as, soy and pea
proteins.7 The polysaccharides include gum Arabic, chitosan, alginate, sodium carboxymethyl
cellulose, and carrageenan.7,26,31 Complex coacervation is used mainly for the encapsulation of
essential oils, some drugs, vitamins, nutraceuticals (e.g.,omega-3) and different various food
ingredients.7
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The complex coacervation method typically involves the five following steps: 7,27
1. Dissolution and hydration of polymers to obtain aqueous solutions of the two polymers,
(either a protein and a polysaccharide or two oppositely charged polysaccharides) at a
temperature and pH above their gelling point.
2. Emulsification step where creating an emulsion of the hydrophobic core material in the
aqueous phase is accomplished. The emulsion is typically stabilized by a surfactant
and/or one of the polymers.
3. Coacervation and shell formation due to changing the reaction conditions, such as
lowering the pH, the two polymers would interact by electrostatic attraction and form a
complex that would eventually deposit on the oily droplets of the core. The pH is one of
the important parameters in this step as it directly affects the degree of ionization of the
functional groups of the polymers.
4. Hardening by means of adding a cross-linker to harden the shell.
5. Separation of the microcapsules which are isolated from the reaction mixture by either
decantation or centrifugation. The microcapsules are usually dried to get a sample in a
powder form.
In spite of the advantages that the complex coacervation technique offers, there are two main
limitations for this method. Firstly, the method is mainly suitable for the encapsulation of
hydrophobic core materials and is not ideal for encapsulating hydrophilic cores. However, the
introduction of some changes to the conventional coacervation method enables the incorporation
of hydrophilic cores, such as including a double emulsion step which comprises the formation of
a primary w/o emulsion in the beginning of the process before coacervation, followed by a
double w/o/w emulsion.32-34 Although the double emulsion method is reported to be effective in
encapsulating hydrophilic substances, it adds to the cost of the process.7 The second
disadvantage of this method is that the majority of the articles in the literature cited the use of
toxic aldehydes (e.g., formaldehyde, glyoxal and glutaraldehyde) as cross-linkers for the wall
polymers, which is not legislated in some countries.35 This problem could be solved by using
non-toxic hardening agents, such as transglutaminase enzyme36, genipin37 or tripolyphosphate.38
In this study, two hardening agents were used; the polyanion tripolyphosphate and tannic acid,
which are both reported to be non-toxic and environmentally friendly.38,39
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2.3 Microcapsules wall material: Biodegradable polymers
There is a wide variety of natural and synthetic shell materials that are used in
microencapsulation. The choice of the appropriate coating material depends on the final product
objective and requirements; as it will determine the final properties of the resulting
microcapsules. The product requirements may include a specific controlled release profile,
reduction of volatility, adding value and functionalization or stabilization of an active agent.
Moreover, the resulting encapsulation efficiency should be taken into consideration. The ideal
polymer should be non-toxic, insoluble and non-reactive with the material intended to be
encapsulated and should readily deposit on its surface to form a cohesive film of a suitable
thickness around it.17 The selection criteria may also be influenced by economic factors. The use
of natural biodegradable polymers has been recently of high interest; mainly because they are
naturally abundant, eco-friendly and biocompatible. Biodegradable polymers, both natural and
the synthetic, are known to be eco-friendly due to their capability to cleave into biocompatible
products through chemical or enzymatic hydrolysis.40 Biodegradable polymers are also able to
release the active agent in a controlled pattern. Examples of synthetic biodegradable polymers
that are used in drug microencapsulation include polyesters, polyorthoesters, polyphosphazenes
and polyanhydrides, while natural biodegradable polymers are either based on proteins (such as
gelatin, albumin, and collagen) or polysaccharides (such as, chitosan, hyaluronic acid, gum
Arabic, alginate, maltodextrin, starch, ethyl cellulose and carrageenan).11,40 Owing to the fact
that one wall material may not possess all the desired requirements for a certain application, a
combination of different encapsulating materials is sometimes used.11
2.3.1. Chitosan
Chitosan has recently acquired great attention in different areas due to its interesting properties,
such as being non-toxic, biodegradable, non-allergic, mucoadhesive, excellent film forming
ability and being a potent antimicrobial agent.41,42 It has been widely used in several industrial
applications, such as food engineering and packaging, wastewater treatment, cosmetics, textile
coating, pharmaceuticals, biomedicine and tissue engineering. Chitosan is a linear
polysaccharide made of β- (1→4) linked monosaccharide units of β-(1,4)-2- amino-2-deoxy-Dglucose (Figure 2.4). It is a biodegradable polymer derived from chitin, which is the second most
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abundant polysaccharide in nature.11,40 Chitin occurs mainly in the skeletons of crustaceans,
insects and in the cell wall of some fungi. The acetamide (N-acetyl) group in chitin is chemically
converted by alkaline treatment into an amino group to obtain chitosan. The degree of
deacetylation “DDA” is a term that shows the amount of 2-amino-2-deoxy-D-glucose (Dglucosamine) units in a molecule of chitosan.43 The commercially available chitosan is known to
have a DDA of 66% to 98%. At alkaline and neutral pH, chitosan has free amino groups and
therefore, it is insoluble in water. At acidic conditions, the amino groups become protonated, and
hence chitosan becomes soluble.44

Figure 2.4 Chemical structure of (a) chitin and (b) chitosan. Adapted from Ref. 44.
The DDA of chitosan affects its solubility; since it reflects the amount and distribution of the free
amino groups in relation to the remaining N-acetyl groups.42,43 The DDA also influences the
complexation ability of chitosan since a higher DDA results in a higher charge density and
greater complex formation capability.43 Additionally, the biodegradability of chitosan is affected
by its DDA.11 The biodegradability of chitosan is of high importance for the release of the
encapsulated material. It has been reported that the variations in the DDA of chitosan affects the
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release profile of the drug isoniazid, and that the higher the DDA of the chitosan used, the faster
the reported rate of release.45
The antibacterial activity of chitosan pertains to the positive charge on its protonated amino
groups.41,46 The DDA and the pH define the extent of the charge density of chitosan, and hence,
its antibacterial activity. The majority of amino groups on C-2 of chitosan acquire cationic
charge at low pH (lower than its pKa ~ 6). This protonation enhances the interaction between
chitosan and the anionic charges of lipopolysaccharides on the surface of the Gram negative
bacteria, and with the anionic peptidoglycans in Gram positive bacteria.47 Consequently, these
interactions lead to changes and disruption in the permeability of the bacterial cell and leakage of
the vital intracellular substances; which affects the functions and bioactive processes of the
microorganism and finally its death.48,49
Cross-linking of chitosan involves the introduction of intermolecular bridges between the
polysaccharide macromolecules by using specific reagents known as cross-linkers.50 Crosslinking reactions are known to decrease the mobility of the polymer segment and results in the
interconnection between the polymer chains through new linkages.11,50 It has been reported that
the cross-linked chitosan microcapsules are more efficient for the controlled release applications
as compared with those that are not cross-linked.50 The cross-linking reaction is affected by the
size and kind of the cross-linking agent used. Generally, the smaller the size of the cross-linker,
the faster the reaction; as its diffusion between the function groups of the polymer becomes
easier.51 According to the interaction of the cross-linker with chitosan, the cross-linking reaction
can be classified into chemical or physical. The chemical cross-linking results in networks made
by permanent covalent bonding between the chitosan chains. The amino and the hydroxyl
groups of chitosan are the cross-linking sites that form ester linkages, amide linkages, and
sometimes Schiff bases. The chemical cross-linking reaction depends mainly on the
concentration of the cross-linkers, as well as the exposure time. Examples of well-known
chemical cross-linkers are genipin, glutaraldehyde, vanillin which forms a Schiff base, and
epichlorohydrin.50 The physical cross-linking depends on electrostatic interactions between the
chitosan and the counterions. The physical cross-linkers are polyanionic compounds and they
include phosphoric acid salts (e.g., tripolyphosphate), citric acid, and sulfate.11,50,51
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2.3.2. Gum Arabic
Gum Arabic (GA) is the dried exudate of Acacia senegal and Acacia seyal trees, Family
Leguminosae.52 Sudan, Nigeria, Chad, Ethiopia and Senegal are the main producers. It is
harvested as dried sap (Figure 2.5). The use of GA dates back to the time of ancient Egyptians;
as they used it as a binder in paints, inks, cosmetics and in embalming mummies. 53 It is now
widely used in food, pharmaceutical and cosmetic industries for its notable stabilizing, binding,
thickening and emulsifying properties. It is also used in the textile industry to thicken the
printing pastes which are used in the coloration of cellulose fabrics.53 GA is also reported to have
antimicrobial effects against some fungal pathogens, such as Candida albicans and Cryptococcus
neoformans.52
GA is a branched heteropolysaccharide polymer that exists as a mixture of calcium, potassium
and magnesium salts. 53 The main fraction of GA (88-90%) is composed of two chains: the main
chain consists of 1,3-linked β-D-galactopyranosyl units, while the side chains consist of two to
five units of 1,3-linked β-D-galactopyranosyl units joined by 1,6-linkages. Both chains contain
α-L-arabinofuranosyl, α-L-rhamnopyranosyl, β-D-glucuronopyranosyl and 4-O-methyl-β-Dglucuronopyranosyl units.

52-54

The secondary fractions (10%) is composed of both complex

arabinogalactan-protein (AGP) and glycoprotein (GP).55

Figure 2.5 Gum Arabic exudate on Acacia tree. Adapted from Ref. 52.
GA is widely used in microencapsulation due to its low viscosity, excellent emulsification
properties, high solubility in water, film-forming capability and high ability to retain and protect
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volatile compounds.56 It is believed that the emulsifying ability of gum Arabic is related to the
AGP complex in its structure; since it is an amphiphilic protein component that can deposit on
the surface of the oil droplets, while the carbohydrate fraction remains directed to the aqueous
phase preventing the coalescence of the oil phase droplets.55

2.4. Microcapsules core material
2.4.1. Vanillin
The core material is the substance present in the inner part of the microcapsule over which the
shell material is applied. Vanillin (Figure 2.6) is one of the most widely used flavoring agents
and it is generally regarded as safe (GRAS). It is a plant metabolite obtained from the beans or
pods of the tropical orchid Vanilla planifolia. It is native to Mexico and Central America, and is
now cultivated in Madagascar, Indonesia, Uganda and Guinea. Madagascar is the largest
producer followed by Indonesia

57,58

Due to the high cost of the process of growing and

harvesting the vanilla orchid, most of the vanillin used in pharmaceuticals, perfumery, food
products, and cosmetics is chemically synthesized. In fact, the naturally used vanillin makes up
only less than 1% of the total vanillin produced worldwide.59

Figure 2.6 Structure of vanillin (4-hydroxy-3-methoxybenzaldehyde).
The volatile nature of vanillin and its limited solubility in water make its use in different
applications problematic.60,61 Moreover, the presence of a phenolic and an aldehydic group in its
structure makes it highly susceptible to oxidation and thermally unstable.62 Therefore, its
protection by encapsulation is worth investigating to increase its stability and functionality.
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Table 2.1 represents examples of the different methods that have been reported on vanillin
microencapsulation.
Vanillin has been reported to possess several bioactive effects, such as antioxidant,
antimicrobial, anticarcinogenic and antimutagenic properties.57 Vanillin is incorporated in a lot
of food preparations not only for being a sweet flavoring agent, but also due to its antimicrobial
property making it into a “phytopreservative” or a “green preservative”,63 which satisfies the
needs of consumers who look for natural additives rather than chemical ones. It has been
reported to have a potent antimicrobial activity against gram negative and gram positive
bacteria,64,65 yeasts and molds. Vanillin antibacterial activity has been recognized against
Staphylococcus aureus, Staphylococcus epidermidis, Enterobacter aerogenes, Escherichia coli,

Listeria monocytogenes and Yersinia enterocolitica which are known to cause skin diseases and
gastrointestinal tract problems.62,66 The antibacterial activity of vanillin depends on its
concentration, exposure time and the target microorganism.46 It has also been reported that the
antifungal activity of vanillin is attributed to its aldehyde moiety and the position of the side
groups on its benzene ring.67
Recent studies also demonstrated the ability of vanillin to protect against chronic depression and
induce relaxation through olfaction and oral adminstration.68,69 It is claimed that the
antidepressant effect of vanillin is connected to its adrenergic agonistic activity.69 Furthermore, it
was found that the exposure to a familiar vanillin scent decreases neonates’ crying that
accompany pain attacks and alleviates the concomitant symptoms, such as energy depletion and
increased risk of hypoxemia.70
To the best of our knowledge, the microencapsulation of vanillin using complex coacervation
method has not been previously reported.
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Table 2.1 Examples of different methods of vanillin microencapsulation and their area of
application.
Method

Wall material

Application

Reference

Spray Drying

Chitosan

Textiles

60

Phase Inversion by

Polysulfone

Textiles

64,71

β-CD

Food preparations

72

Food preparations

73

immersion precipitation
Spray-freeze drying

WPI
β-CD + WPI
Spray Drying

Sodium alginate
Methyl β-CD
Inulin
Hydroxypropylmethyl cellulose

Spray Drying

Soy protein isolate-maltodextrin

Food preparations

13

Emulsion stabilization

Carnauba wax

Food preparations

74

Maltodextrin
β-CD
Gum Arabic
Freeze-drying

β-CD

Food preparations

75

Multilayer emulsion

Soy protein isolate

Food preparations

76

and spray drying

Modified starch
Chitosan
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2.4.2. Limonene
D-limonene (Figure 2.7) is one of the most abundant terpenes that occur naturally. It represents
the main constituent in the essential oils of citrus fruits, such as orange, lemon, lime and
grapefruit. Its optical isomer is L-limonene; it has a turpentine odor and is mainly found in the
volatile oils of pine and oak trees.77 D-limonene is listed as a GRAS compound in the Code of
Federal Regulations, and is used widely in the food and cosmetic industries as an important
flavor and fragrance.78 It is clinically used to dissolve gallstones and treat heartburns.78,79 It has
been also reported to have an anti-tumor and chemo-preventive activity against mammary, colon
and lung cancers.80 D-limonene has also been reported to lower the risk of skin carcinoma.81

Figure 2.7 Structure of d-limonene (4-isopropenyl-1-methylcyclohexene).
D-limonene has a potent antimicrobial activity against several bacteria such as Salmonella spp.,82
E. coli,83 Staphylococcus aureus and Pseudomonas aeruginosa.84 Antifungal properties of dlimonene have been also reported.85 The chemical structure of the essential oil denotes its
antibacterial behavior. Limonene has more potent antibacterial activity than p-cymene; because
the alkenyl group of the former is oxidized upon exposure to air and forms ions that disturbs cell
wall, which is not the case of the alkyl group of the latter.86 Limonene is capable of penetrating
the lipid barrier in the bacterial cell wall. This results in the denaturation of the protein
components of the bacterial cell membrane, causing the leakage of the cytoplasmic constituents
which in turn disrupts the energy status and eventually leads to cell death.83,86
Table 2.2 shows different methods that have been reported on limonene microencapsulation and
the wall materials used in each method. Much has been published about the encapsulation of
limonene with various methods including complex coacervation; yet most of the literature
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available on the microencapsulation by complex coacervation refers to the use of pairs of wall
materials other than the chitosan and gum Arabic together. Leclercq et al.87 compared limonene
protection against oxidation to limonene oxide by both complex coacervation and spray drying
methods. They reported that microencapsulation by complex coacervation has fully protected
limonene against oxidation to limonene oxide during 25 days of storage, whereas high amount of
limonene oxide was produced over the same duration when spray drying technique was used.87
Table 2.2 Examples of different methods used for limonene microencapsulation and their area of
application.
Method

Wall material

Application

Reference

Complex coacervation

Chitosan/gelatin

Textiles

88

Complex coacervation

Gelatin/carboxymethyl cellulose

Footwear

89

In situ polymerization

Melamine-formaldehyde resin

Footwear

89

Complex coacervation

Gelatin/gum Arabic

Flavors

87

Spray drying

Gelatin/gum Arabic

Flavors

87

Interfacial polymerization

Polyurethane-urea

Textiles

90

Simple coacervation

Chitosan

Non-woven Fabrics

91

Spray drying

Gum Arabic/maltodextrin

Flavors

92

Ultra-high pressure

Gelatin/sucrose/gum Arabic

Flavors

93

Molecular inclusion

β-CD

Flavors

94

Simple coacervation

Gum Arabic

Textiles

95

homogenization and
freeze drying

2.5. Release Mechanisms
Microencapsulation allows effective shielding and protection of the active agent from
degradation by the surrounding environment. At the same time, it offers controlled release of the
active agent over long periods. The rate of the controlled release depends on the nature of the
coating material, its thickness and porosity.17,96 Moreover, it depends on the physiochemical
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properties of the active agent, such as its solubility, partition coefficient and diffusibility across
the polymeric matrix.96
The term controlled release includes different types of release profiles such as sustained release,
triggered release, pulsed release and targeted release.97 There are several release mechanisms by
which the core material is being gradually liberated out of the microcapsules, and in general, the
release mechanism depends on the intended application of the microcapsules.19 The following
are examples of the main release mechanisms associated with microencapsulation:
1.

Diffusion through the wall material

Diffusion involves the penetration of the shell material by the dissolution fluid surrounding the
microcapsules, which subsequently dissolves the core and results in the leaking out of the core
material through the pores or interstitial channels of the wall material.17 Diffusion is the most
commonly involved release mechanism in pharmaceutical preparations as it allows for the
sustained release of the microencapsulated drug.17,19
2.

Dissolution of the wall material

In this mechanism, the release of the active agent occurs when the coating material dissolves in
the dissolution fluid. The thickness of the microcapsule wall and its degree of solubility in the
dissolution fluid determines the release rate.17 This release mechanism is typically utilized in
detergent preparations where the dissolution of the wall material of the microcapsules in the
detergent powder liberates the encapsulated protease enzyme which has the ability to remove the
stains from clothes. It is also utilized widely in the food industry, where microencapsulated
ingredients such as nutrients, taste enhancers, or flavoring agents (e.g., in chewing gums) are
liberated through the melting of the wall material.19
3.

Mechanical rupture of the wall

The mechanical rupture of the microcapsule shell immediately releases the core contents. The
rupture can be either achieved by applying pressure (such as in carbonless copy paper) or by
scratching (as in case of scratch and sniff perfumes).19
4.

Degradation and Erosion of the wall

The erosion of certain coating materials causes the gradual release of the core material. 17,98
Erosion can be classified into surface and bulk erosion, according to the chemical structure of the
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polymer. When the rate of the polymer erosion is higher than the rate by which water permeates
into the bulk of the polymer, the erosion is said to be surface erosion and the release follows zero
order kinetics. However, bulk erosion occurs when the rate of water permeation is higher than
the polymeric system erosion causing complex release kinetics.99,100 The majority of the
biodegradable polymers exhibit bulk erosion. Erosion is a physical phenomenon that depends on
diffusion and dissolution, whereas degradation is a chemical phenomenon. The degradation of
the majority of the biodegradable polymers occurs by the bulk hydrolysis of the polymer into
smaller fragments. Nevertheless, some biodegradable polymers, such as polyanhydrides and
polyorthoesters, degrade only at the surface, exhibiting a release rate for the core material
proportional to the surface area of the coating material. 100

2.6. Applications of microencapsulation
2.6.1. Food Industry
Microencapsulation technology has recently been employed in the food industry.20 It allows for
the incorporation of important ingredients, such as flavoring agents, polyphenols, vitamins,
volatile additives, antioxidants and enzymes in different food products, and thus protecting these
ingredients from degradation. Microencapsulation is also used in food packaging technologies
where it permits the incorporation of antimicrobial agents in the packaging material to protect
food against different foodborne pathogens.5 It is also used in the food industry to retard the rate
of evaporation of volatile cores to the surrounding environment or to control their release rate
over time or until reaching a specific stimulus.11 In addition, microencapsulation is applied in the
food industry to mask the flavor of the core material; to separate different components that are
reactive with one another within the product; or to modify the physical characteristics of the core
material so that it becomes easier and more convenient to handle.1,11 Microencapsulation of
probiotic bacteria has been recently used to enhance their bioavailability and targeted delivery in
the gastrointestinal tract.101
2.6.2. Pharmaceuticals
Microencapsulation has various applications in the pharmaceutical industry. It provides a lot of
advantages over the conventional drug systems, such as sustained release, protection of the drug,
prolongation of shelf-life and targeted drug delivery.4 It is also used to mask the unpleasant taste
24

of some components in the pediatric and geriatric drug formulations.102 Bioencapsulation is one
of the important pharmaceutical and medical applications of microencapsulation. It involves the
entrapment of biologically active materials, such as DNA and cells. Encapsulation of DNA
vaccines in polymeric microcapsules, such as poly lactic-co-glycolic acid (PLGA), offers slow
release rate, and thus prolonged immune response.4 Another example includes the encapsulation
of certain human tissues by natural polymers prior to their transplantation to manage some
hormone deficient diseases (e.g., diabetes).8
2.6.3. Cosmetics
Microencapsulation in cosmetics covers a wide range of applications, including hair and skin
care and maintenance products, oral cavity and mucous membrane products (e.g., toothpaste),
perfumes, hair products, cleansing products, correcting body odor products, makeup and
decorative cosmetics.103 Innovation, cost, and meeting the consumer demands drive the
microencapsulation research and development in the cosmetic industry and perfumery.22,104
There are various examples of core ingredients that are being microencapsulated in cosmetics,
such as skin moisturizers, vitamins, essential oils, antimicrobials, and colorants.9,103,105
2.6.4. Agriculture
Microencapsulation is widely applied in the area of agriculture; either for crop protection106 or
promoting plant growth.19 Microencapsulation of nitrogen-fixing bacteria in biodegradable
polymers was investigated in one of the recent studies using spray drying methods which help in
the growth of plants without the use of excessive chemical fertilizers.107 Furthermore,
microencapsulation of pesticides and insecticides allows for plant protection while reducing
human, animal and soil toxicity. Additionally, it helps in elongating the duration of activity of
the pesticide and controls its rate of evaporation.108
2.6.5 Textiles
The application of microencapsulation in textile industry started in the early 90s; with very few
commercial products. However, by the beginning of the 21st century, the number of applications
has shown a visible growth, specifically in Japan, North America, and the countries of Western
Europe.109 Microencapsulation permits the incorporation of different active agents onto textiles,
and thus provides an added value to them. The core material is responsible for the new properties
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of the fabric, and hence defines its function. Examples of microencapsulation applications in
textiles include durable fragrances, skin softeners, vitamins, insect repellents, phase-change
materials, color changing fabrics, cosmetotextiles, and medical textiles.109,110
Different attempts to incorporate aroma onto textiles have been carried out for many years.
Microencapsulation allows for higher durability and release of fragrances over a longer period.
Fragrant textiles are frequently used in aromatherapy; a field which relates fragrances with
psychology and how they can trigger specific feelings, such as happiness, relaxation, excitement,
or well-being.111 Numerous essential oils such as, lavender, citrus, vanilla and rose have been
applied to fabrics designed for aromatherapy. Each essential oil is reported to initiate a particular
emotion and acts as a healing element.112
‘Cosmetotextiles’ is a term given to fabrics designed to be in direct contact with the skin, and
contain personal care active agents, such as skin softeners, slimming agents, moisturizers, anticellulite, UV-protecting and anti-ageing ingredients.113-115 Those active ingredients are integrated
in the fabrics by microencapsulation techniques, and are released to the skin by mechanical
means, such as friction and abrasion.113
Imparting antimicrobial properties to textiles has been one of the important applications of
microencapsulation in textile industry. Textiles that are made of natural fabrics, such as cotton
and wool are known to furnish excellent media for microbial growth due to their ability to hold
humidity and highly porous structure that increases their surface area.41,116 A myriad of
antimicrobial substances have been incorporated onto textiles. Natural antimicrobials have
recently gained increasing interest due to their being safe, eco-friendly and originating from
renewable sources.
Another important textile application of microencapsulation is in the area of defense where
chemical decontaminants are microencapsulated within certain polymeric shells. Theses shells
are selectively permeable to toxic substances and partially permeable for the decontaminating
core materials, and hence allowing the diffusion of the toxic chemicals into the core of the
microcapsules where they become irreversibly detoxified by means of chemical reactions.19
The process of adhesion of the microcapsules onto the fabric is an important factor to consider in
microencapsulation application in textiles; because it directly affects the stability and the
durability of the finished product. There are different methods by which microcapsules can be
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applied to the fabrics, such as spraying, foaming, grafting through chemical links,60
impregnation,117 coating, printing, padding and bath exhaustion. Padding is usually followed by
drying and curing of the treated fabrics, and hence, the conventional process is known as the paddry-cure method. The most widely used binding method in industry is padding. It involves
soaking of the fabric in a bath that contains the microcapsules, resin and water and then passing
the fabric through a padder (foulard). This subsequently entails applying a stream of hot air as a
thermal treatment to cure the binding resin and adhere the microcapsules to the fabric. 118
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Chapter 3: Materials and Methods
3.1. Materials
The reagents and chemicals used in the preparation and characterization of the microcapsules are
listed in table 3.1.
Table 3.1 List of used chemical compounds, their functions and suppliers.
Chemical Compound

Function

Supplier

Gum Arabic

Wall material

Sigma Aldrich

Chitosan

(Degree

of Wall material

BioLog

deacetylation 88-95%)

Und

Biotechnologie

Logistik

GmbH

(Germany)
Vanillin

Core material

Sigma Aldrich

(R)-(+)-Limonene

Core material

Sigma Aldrich

Tween® 20

Emulsifier

Sigma Aldrich

Tergitol, type 15-S-9

Emulsifier

Sigma Aldrich

Span 85

Emulsifier

Sigma Aldrich

PGPR 4150

Emulsifier

Palsgaard® (Denmark)

Corn oil

Carrier and solvent for vanillin

Sigma Aldrich

Hydrochloric acid 0.2 N

pH adjustment

Sigma Aldrich

Acetic acid 0.1 N

Solvent for chitosan

Sigma Aldrich

Sodium TPP

Hardening agent

Sigma Aldrich

Tannic acid

Hardening agent

Merck

n-Hexane

Washing reagent

Carlo Erba Reagents

Citric acid

Grafting of microcapsules onto Sigma Aldrich
fabrics

Sodium phosphate

Catalyst for grafting reaction

monobasic monohydrate
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Sigma Aldrich

Table 3.2 lists the cotton fabrics that were used for the application of the produced
microcapsules. Fabrics dimensions were chosen according to the required impregnation method
(whether simple coating or thermofixation method). All the fabrics were purchased from SDC
Enterprises Limited, UK.
Table 3.2 List of the cotton fabrics used.
Fabric

Dimensions

Product Code

Cotton Lawn

30cm x 25cm

1305 SDC

Cotton Lawn Rubbing Fabric

20cm x 10cm

1351 SDC

Cotton Limbric Gimped

10cm x 4cm

1531 SDC

3.2. Experimental Methods
3.2.1. Production of Microcapsules
The process of both vanillin and limonene microcapsule formation involved three main steps:
emulsification, complex coacervation induction and finally, the hardening of the formed
microcapsules. Owing to the fact that vanillin is in a solid form and hydrophobic, corn oil was
used to dissolve it and to permit its emulsification. Several preliminary formulations were
produced until a final optimized formulation was obtained. These trials will be discussed in
chapter 4, whereas the final microencapsulation formulation is discussed in this section. The
method for the production of microcapsules was adapted from procedures described in previous
reports1,2 but with some modifications.
3.2.1.1. Production of Vanillin Microcapsules
1. Emulsification
1.0% (w/v) of chitosan solution was prepared by dissolving 0.5 g of chitosan in 50 mL of 0.1N
acetic acid and was left overnight to be completely dissolved. 0.12 g of vanillin was dissolved in
4.5 g of corn oil which was heated at 40°C and was added to the chitosan solution. 50 mL gum
Arabic solution (2.0%, w/v) (which was prepared in deionized water), and a specified amount of
the emulsifier was added to the mixture. Then, emulsification was generated by continuous
mechanical agitation; through keeping the system under stirring at 8000 rpm with a homogenizer
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(an ultraturrax IKA DI 25 Basic, yellow line) (Figure 3.1; Table 3.3), for 1 minute at 40⁰C to
form an O/W emulsion.
2. Induction of complex coacervation
Complex coacervation was initiated by decreasing the stirring speed to 400 rpm, and the pH
value of the mixture was adjusted from 6 to 3.5 with 0.2 N HCl. The mixture was left under
continuous stirring for 30 minutes, and then it was cooled to 5⁰C by means of an ice bath.
3. Hardening of microcapsules
Consolidation of the produced microcapsules was done by the dropwise addition of the
hardening agent (either solution sodium TPP or tannic acid) to the suspension of the
microcapsules with continuous stirring (400 rpm) for 3 hours at 5⁰C. The microcapsules mixture
was then left for decantation to allow phase separation.

Figure 3.1 IKA® DI 25 Basic Ultraturrax.
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Table 3.3 Specifications of the homogenizer used in the formation of microcapsules.3
Manufacturer

IKA

Model

DI 25 Basic

Dispersion tool working range

10-1500 ml

Speed range

8000-24000 rpm

3.2.1.2. Production of Limonene Microcapsules
The final method used to produce limonene microcapsules was similar to that used for the
preparation of vanillin microcapsules by complex coacervation (in Section 3.2.1.1), except for
the volume and nature of the core material. Being a liquid, limonene was used directly as the oil
phase in the O/W emulsion without the need to dissolve it in a suitable oil, as was previously
done with vanillin.
1. Emulsification
1.0% (w/v) of chitosan solution was prepared by dissolving 0.5 g of chitosan in 50 mL of 0.1N
acetic acid and was left overnight. One gram of limonene was added to the prepared chitosan
solution. Then 50 mL gum Arabic solution (2.0%, w/v) (which was prepared in deionized water),
and a specified amount of the emulsifier was added to the mixture. The system was maintained
under stirring at 8000 rpm with the homogenizer for 1 minute at 40⁰C to form O/W emulsion.
2. Induction of complex coacervation
To start complex coacervation, the stirring speed was set to 400 rpm, and the pH value of the
mixture was adjusted from 6 to 3.5 with 0.2 N HCl. After stirring for 30 min, the mixture
solution was cooled gradually to 5⁰C by means of an ice bath.
3. Hardening of microcapsules
The method used for the hardening of vanillin microcapsules was also applied for limonene
microcapsules (Section 3.2.1.1) and the microcapsules mixture was then left for decantation to
allow phase separation.
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3.2.2. Characterization Methods
3.2.2.1. Optical Microscopy
The morphology of the obtained microcapsules was examined by means of a Leica DM 2000
optical microscope equipped with Leica Application Suite Interactive Measurement imaging
software (Figure 3.2). Different magnifications (100x, 200x, 400x, and 1000x) were used to
observe the produced microcapsules.

Figure 3.2 Optical microscope, Leica DM 2000.
3.2.2.2. Particle Size Evaluation
Mean particle size and size distribution of the produced microcapsules were determined by a
Beckman Coulter Laser Diffraction Particle Size Analyzer LS 230 (Figure 3.3). The Coulter LS
200 Series uses reverse Fourier lens optics incorporated in a binocular lens system, which
enables the optimization of light scattering across a wide size range in a single scan with high
data reproducibility.4 The size distribution measurements were done in both volume and number
for all samples.
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Figure 3.4 Laser Diffraction Particle Size Analyzer, Beckman Coulter LS 230.
3.2.2.3. Scanning Electron Microscope (SEM)
A high-resolution (Schottky) Environmental Scanning Electron Microscope with X-Ray
Microanalysis and Electron Backscattered Diffraction Analysis: Quanta 400 FEG ESEM/EDAX
Genesis X4M operating at 15.00 kV was used to examine the morphological features of the
produced microcapsules (Figure 3.5). Microcapsules were freeze-dried and then coated with a
thin film of gold and palladium, by sputtering, using the SPI Module Sputter Coater equipment
(Figure 3.6) prior to SEM analysis. Textile samples were directly examined without being
previously coated.
For some SEM examinations, a Phenom ProX desktop scanning electron microscope (Figure
3.7), equipped with Elemental Identification (EID) software with Energy Dispersive
Spectrometer (EDS) was used.
Freeze-drying was done by placing the microcapsules for 24 hours in a Scanvac CoolSafe 55-4
Basic 4lt freeze dryer, operating at about -50ºC and 0.2 mbar, after being separated by
decantation.
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Figure 3.5 Scanning electron microscope FEI Quanta 400 FEG ESEM / EDAX Genesis X4M.5

Figure 3.6 SPI-Module™ Sputter Coater of the Materials Center of the University of Porto.
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Figure 3.7 Phenom ProX desktop scanning electron microscope.
3.2.2.4. Gas chromatography (GC-FID)
Gas chromatography (GC-FID) was used to quantify the encapsulated and the released vanillin
and limonene. A Varian CP‐3800 gas chromatographer equipped with split/splitless injector, two
CP‐Wax 52CB bonded fused silica polar columns (50 m x 0.25 mm with 0.2 μm film thickness)
and a Varian FID detector operated by the Saturn 2000 WS software was used for the analysis
(Figure 3.8). The injectors were set at 240°C, with a split ratio of 1:50 for FID. The FID detector
was maintained at 250°C. The volume of each injected sample was 0.1μL. The carrier gas was
helium He N60 with a constant flow rate of 1 mL/min.
For the analysis of vanillin, the oven temperature was kept isothermal at 50°C for 5 minutes, and
then increased gradually from 50°C up to 120°C at a rate of 10°C/min, followed by a second
gradual increase to 200°C with a rate of 2°C/min. The total running time for a sample was 73
minutes.
During limonene quantification, the oven temperature was maintained isothermal at 175°C for 7
minutes, and then increased to 220°C with a rate of 10°C /min with a hold of 5 minutes. The total
running time for each sample was 16.5 minutes.
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Figure 3.8 Varian CP‐3800 GC/FID equipment.
3.2.2.5. pH Measurement
Determination of pH was done by a Crison pH meter, model Basic 20 (Figure 3.9), which was
calibrated to pH 4, pH 7 and pH 9 prior to all experiments.

Figure 3.9 Crison Basic 20 pH meter.
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3.2.2.6. Solid Content Determination
Solid content of the microcapsules was determined according to the European Standard EN 827
for the determination of solid content in a water based adhesive. It involves measuring the
difference between the initial mass and the final mass of microcapsules samples after water
evaporation. The test was done by placing about one gram of the microcapsule suspension on a
watch glass and allowing it to be dried in an oven at 100°C for 30 minutes, then placing the
sample in a desiccator for 15 minutes and weighing the residual mass. The drying step was
repeated until the difference between the initial mass and the residual mass (mass final) did not
exceed 2 mg.6 The solid content was calculated according to equation 3.1:
% Solid Content = mass final x 100
mass initial

(3.1)

3.2.3. Release Measurements
The release studies of vanillin and limonene were performed by using the produced
microcapsules suspensions after being washed with hexane. The measurements involved
quantification of the free active material (vanillin or limonene) after being released from the core
of the microcapsules to the microcapsules surrounding phase. The method was adapted from a
previously reported study,7 but with few alterations.
Throughout the work, known volumes of washed microcapsules were placed in sealed bottles
and placed in an incubator (Figure 3.10), which was set to specific temperatures and shaking
speeds over a certain duration of time. Samples of the incubated microcapsules suspensions were
collected at predetermined time intervals. Subsequently, the microcapsules surrounding phase
was separated from the loaded microcapsules in the suspension by a syringe equipped with a 0.2
µm pore size polypropylene filter (VWR International - Material de Laboratório, Lda). The
concentration of the free vanillin and limonene in the filtered microcapsules surrounding phase
was eventually measured by GC-FID chromatography. Vanillin and limonene release profiles are
presented and discussed in detail in chapter 5.
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Figure 3.10 SI-300R Lab Companion Incubator Shaker.
3.2.4. Fixation of Microcapsules onto Fabrics
3.2.4.1. Simple coating method
Cotton fabrics (10 cm x 4 cm) were submerged in the microcapsules suspension for five minutes
and then were left to dry at room temperature. Samples were cut from different locations on each
fabric. SEM was used to confirm the presence and evaluate the morphology of the microcapsules
on the fabrics. Elemental analysis of the chemical constituents of the microcapsules that coated
the fabric was also done by SEM.
3.2.4.2. Grafting followed by pad-dry-cure method
The application of microcapsules onto the fabrics was also carried out by a chemical grafting
method followed by an impregnation process using a ‘pad-dry-cure’ technique. The method was
adapted from a previous report.8 The chemical adhesion process involved the use of citric acid as
the linker, and sodium hypophosphite as a catalyst. The padding step was done by a Roaches
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foulard, model EHP Padder (Figure 3.11). The padding pressure varied between 0.1 MPa and 0.3
MPa, followed by a drying process in a Roaches thermofixation oven (Figure 3.12), in which the
treated samples were adjusted on a pin frame and exposed to a recirculating heat current that
allowed optimized drying and curing of the microcapsules at different selected temperatures for
specific time.

Figure 3.11 Roaches EHP Padder, the laboratory foulard used in the fixation of the formed
microcapsules onto the fabrics.

Figure 3.12 Roaches laboratory thermofixation oven, model Mini Thermo.
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Chapter 4: Production and Characterization of Vanillin and Limonene
Microcapsules by Complex Coacervation
4.1. Introduction
Complex coacervation is one of the most suitable methods used to encapsulate fragrances and
flavors; because it reduces or prevents the loss of the volatile compounds since it does not
require high temperature.1 In spite of the fact that the exact mechanism has not yet been fully
elucidated, complex coacervation is regarded as a phase separation process that depends on
complex formation between oppositely charged polymers via electrostatic attractions, formation
of hydrogen bonds or hydrophobic interactions.2 The majority of the studies reported in literature
have investigated the combination of a protein and a polysaccharide in complex coacervation,
namely gelatin (an example of a positively charged polymer) and gum Arabic (an example of a
negatively charged polymer). Gelatin/gum Arabic is considered the most common pair of
complex coacervation and has been widely applied in carbonless paper production and in the
encapsulation of flavors and fragrances.3 However, due to some religious and ethnic constraints4,
and some health concerns related to emerging diseases, such prion diseases, the use of gelatin is
sometimes not preferred and is replaced with a different positively charged polymer, which can
be a protein or a polysaccharide.3
A cross-linking agent is added in the last step of the coacervation process to harden the formed
shells of the microcapsules and stabilize their structure.5 Formaldehyde and glutaraldehyde are
widely used as hardening agents for the microcapsules, and are reported to be toxic and are
banned in some countries.6 Thus, they are being replaced with eco-friendly hardening agents.
Moreover, it has been reported that when glutaraldehyde was used to harden the microcapsules
of gelatin and gum Arabic, the crosslinked microcapsules had a tendency to aggregate and
showed a poor state of dispersion.7 Therefore, the use of safe and eco-friendly microcapsules
hardening agents has recently substituted these conventional cross-linking agents. These
hardening agents include sodium tripolyphosphate8, tannic acid, glycerol, transglutaminase and
genipin.2,9
In the work presented here, sodium tripolyphosphate and tannic acid (Figure 4.1) were examined
individually as hardening agents instead of the conventional aldehyde compounds. Sodium
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tripolyphosphate (TPP) is a multivalent anion; carrying five negative charges and hence, is able
to interact with the positively charged –NH3+ groups of chitosan through electrostatic
attraction.8,10 Sodium TPP is a non-toxic FDA approved compound and is ‘generally regarded as
safe’ (GRAS).11
Tannic acid is a natural plant polyphenol, which has the ability to bind to polymers, e.g., gelatin,
carrageenan and chitosan through hydrogen bonding and hydrophobic interactions.7,12-14

Figure 4.1 Structure of (a) sodium TPP and (b) tannic acid. Adapted from Ref. 10 and 14.
According to their internal structure,15 microcapsules can be classified into two types either
reservoir or monolithic (Figure 4.2). Reservoir microcapsules can be either mononuclear or
polynuclear (multinuclear), whereas the monolithic microcapsules are formed of a matrix of the
internal phase and the wall material.16

Figure 4.2 Types of microcapsules. Adapted from Ref.16.
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Mononuclear microcapsules are produced when an oil droplet becomes encapsulated with the
polymer(s) whereas the polynuclear microcapsules are formed as a result of aggregating
mononuclear microcapsules.5,15 This aggregation can be hindered by modifying the hardening
process, using particular wall materials or making changes in the coacervation process
parameters.15 It has been reported in literature that the change in the agitation speed of dispersion
during the preparation of the microcapsules by complex coacervation could lead to the change in
their morphology. According to Jégat et al,17 multinuclear microcapsules were formed when low
stirring speed was applied (less than 1000 rpm) while the proportion of mononuclear
microcapsules increased when the speed exceeded this value. Nevertheless, Dong et al.15
obtained multinuclear microcapsules by complex coacervation when a stirring speed of 10,000
rpm was applied for 3 minutes.
Current investigations on microencapsulation by coacervation typically focuses on mononuclear
microcapsules and overlooks the study of the polynuclear microcapsules, although the
polynuclear microcapsules have been recently reported to exhibit better sustained release than
the mononuclear ones.5,15
Factorial designs are often applied in the experiments related to the microencapsulation research.
These designs involve changing one factor, which will act in an additive manner when keeping
the other variables constant within the same study.18
This chapter investigates the encapsulation of vanillin and limonene by complex coacervation
method using chitosan/gum Arabic as encapsulants. Two green hardening agents; tannic acid and
sodium tripolyphosphate were investigated and their effect on the microcapsule size, morphology
and encapsulation efficiency was examined. Moreover, the influence of different emulsifiers
(Tween 20, Tergitol, Span 85 and polyglycerol polyricinoleate (PGPR)) on the morphology,
dispersion, encapsulation efficiency and the size of the formed microcapsules were studied.

4.2. Materials and Methods
4.2.1. Materials
The chemical compounds and reagents used in this chapter were previously mentioned along
with their suppliers in Chapter 3, Section 3.1.
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4.2.2. Methods
The general method of the preparation of the microcapsules is comprised of four main steps and
was adapted from some methods previously described in the literature8,19,20 but with some
modifications that principally involved changing the type and amount of the core material, along
with the type and amount of the emulsifier and the masses of the chitosan and gum Arabic used.
The preparation process of the microcapsules is schematically illustrated in Figure 4.3.
The first step involved the dissolution of certain amount of chitosan and gum Arabic. 1% (w/v)
chitosan solution was prepared by dissolving known amount of chitosan in 0.1N acetic acid and
left under magnetic stirring overnight (15 hours) to ensure complete dissolution. 2% (w/v) gum
Arabic solution was obtained by dissolving certain amount of gum Arabic in deionized water
with continuous magnetic stirring at 45ºC for 2 hours.
In the second step, the polymer solutions were mixed together and a known amount of the core
material with a known volume of the emulsifier were added to them. Then, they were all mixed
at a speed of 8000 rpm at 40ºC for 1 minute with a homogenizer to form an O/W emulsion.
Taking into consideration that vanillin is in the form of solid crystals; so it was previously
dissolved in a certain amount of corn oil at 40ºC in a covered beaker for 10 minutes before being
added to the mixture.

Figure 4.3 Schematic representation of the method of microcapsules preparation.
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The third step entailed the induction of complex coacervation by decreasing the pH value to 3.5
with 0.2N HCl and setting the stirring speed of the formed emulsion to 400 rpm. Complex
coacervation is strongly affected by the pH, and it is reported in the literature that the interaction
between chitosan and gum Arabic is maximized within a pH range of 3.5 to 5.21 The pH in this
study was reduced to 3.5; because chitosan has a maximum amount of positive charge in the pH
range of 2.8 to 4, and gum Arabic has negative charges only if the pH is above 2.2.8 After 30
minutes of continuous magnetic stirring, the temperature was gradually decreased from 40ºC to
5ºC with the help of an ice bath.
The last step involved the hardening of the formed microcapsules by drop wisely adding the
cross-linker solution (tannic acid or sodium TPP) at 5ºC and stirring at 400 rpm for 3 hours.
Sodium TPP solution was prepared by dissolving a specific amount in deionized water followed
by the adjustment of pH from 8 to 3.5 by 0.2N HCl before adding it to the final microcapsules
mixture. The ratio of sodium TPP to chitosan in all formulations was 1:2 (wt%).
Here we discuss 15 formulations that were prepared by using either vanillin or limonene as the
core material and examining different emulsifiers (Tween® 20, Tergitol 15-S-9, Span 85, Tween
80 and PGPR) and two hardening agents separately (tannic acid and sodium TPP). The chemical
system of each formulation is summarized in Table 4.1.
4.2.3. Characterization of Microcapsules
The morphology and the dispersion of the microcapsules were investigated by optical
microscope and the mean particle size was determined by laser diffraction particle size analysis.
The encapsulation efficiency of microcapsules was determined by the quantification of the nonencapsulated vanillin or limonene with GC-FID analysis and calculating the masses of the
encapsulated core agents through a method reported previously in Chapter 3 (Section 3.2.2.4.).

4.3. Results and discussion
4.3.1. Encapsulation efficiency
The encapsulation efficiency (EE %) was determined using the following equation:
EE%= mass (total) - mass (non-encapsulated) x 100
mass (total)
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(4.1)

The values of EE % of the formulations are shown in Table 4.1.
Table 4.1 The chemical systems and the EE% of the formulations.
Formulation

Active
agent

Amount
(g)

C

GA

Emulsifier

Amount
(g)

Hardening
agent

Amount
(g)

EE%

1
V
0.3*
2
8
Tween 20
2.58
TPP
1
64.2
2
V
0.3*
2
8
Tergitol
2.58
TPP
1
62.0
3
V
0.3*
2
Tween 20
2.58
TPP
1
30.2
4
V
0.02** 0.5 1
PGPR
0.35
TA
0.2
93.4
5
V
0.12*** 0.5 1
PGPR
0.6
TA
0.2
95.2
6
L
1
0.5 1
PGPR
0.35
TA
0.2
90.4
7
L
4.5
0.5 1
PGPR
0.6
TA
0.2
94.1
8
L
1
0.5 1
PGPR
0.35
TA
0.4
97.3
9
L
4.5
0.5 1
Span 85
0.6
TA
0.2
98.7
10
L
1
0.5 1
Span 85
0.35
TA
0.2
98.6
11
L
1
0.5 1
Span 85
0.35
TPP
0.2
-12
L
1
0.5 1
PGPR
0.35
TPP
0.25
85.3
13
V
0.02*** 0.5 1
Span 85
0.35
TA
0.2
100 a
14
V
0.12*** 0.5 1
Tween 20
0.6
TA
0.2
-15
V
0.12*** 0.5 1
Tween 80
0.6
TA
0.2
-V=vanillin, L=limonene, C=chitosan, GA= gum Arabic, TA= tannic acid, TPP=tripolyphosphate
a
GC/FID peak for the non-encapsulated vanillin could not be detected, and thus the
concentration and mass of the non-encapsulated vanillin was considered zero.
*0.3 g vanillin was dissolved in 20 ml corn oil
**0.02 g vanillin was dissolved in 1 g corn oil
***0.12 g vanillin was dissolved in 4.5 g of corn oil; amount of corn oil is comparable to
limonene.
Comparing the EE% of the first three formulations (where one factor in each was changed and
the others were kept the same), it could be observed that the values showed no big difference
when Tergitol was used as the emulsifier instead of Tween 20. However, when the wall material
contained only chitosan (formulation 3) and no gum Arabic was included, there was a dramatic
decrease in the EE% from 64.2% to 30.2%. This indicates that the presence of gum Arabic in the
shell material along with chitosan not only adds to the compactness and strength of the
microcapsules wall, but also increases the EE%. It could be also explained in terms that the
availability of more polymers in the formulation mixture results in encapsulating higher amounts
of core materials.1
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The use of sodium TPP as hardening agent resulted in the appearance of dark patches, perhaps of
polymer precipitation, that could be seen when the formulations were examined by the optical
microscope without centrifugation (Figure 4.4).
It was also noticed that formulations which contained vanillin as the core material generally had
higher EE% than those which contained limonene. This could be observed when comparing the
formulations that contained the same amounts of limonene and corn oil that was used to dissolve
certain amounts of vanillin, i.e., formulations 4, 5 and 12 with formulations 6, 7 and 9
respectively. (In these formulations, the preparation conditions and chemical systems were kept
the same and only the core material was changed). This might be because vanillin was dissolved
in corn oil that resulted in decreasing its diffusivity through the wall and more core material was
successfully encapsulated. In contrast, in the case of limonene microcapsules limonene was used
purely as the core material, and hence diffused more readily.
The hydrophilic-lipophilic balance (HLB) is a numerical value that reflects the composition of
the emulsifier, regarding its content of the hydrophilic and hydrophobic moieties. Emulsifiers
with low HLB values (4.7-6.7) are usually used to obtain w/o emulsions, whereas o/w emulsions
are obtained by emulsifiers with higher HLB values (9.6-17.6).22 However, some articles in the
literature reported the formation of o/w emulsion followed by complex coacervation by using
emulsifiers with low HLB values (e.g., Span 83).19 It was noticed in this work that the
formulations prepared with Span 85 (HLB=1.8) emulsifier exhibited relatively higher EE% than
formulations prepared with PGPR (HLB=2-4) that had the same other preparation factors. This
could be observed by comparing the EE% of vanillin formulations 5 and 12 (95.2% and 100%),
and limonene formulation pairs 6 and 10 (90.4% and 98.6%), 7 and 9 (94.1% and 98.7%). These
results are in agreement with those obtained by Rabisková et al23 who stated that the use of
emulsifiers with low HLB values (1.8 and 6.7) in the preparation of o/w emulsions for complex
coacervation results in higher values of EE%, indicating the preference of the encapsulation of
hydrophobic materials for emulsifiers with low HLB value. The authors reported the inability of
emulsifiers with high HLB values, such as Tween 81 and Tween 80 (HLB=10 and 15,
respectively) to encapsulate oils by complex coacervation using gelatin and gum Arabic as wall
materials.

56

The encapsulation efficiency obtained by using tannic acid as hardening agent in this study
ranged between 90.4% and 100%. This is significantly higher that what was reported by Pakzad
et al12; who obtained an EE% falling in the range of 53% to 80% by using tannic acid as a
hardening agent for menthol microcapsules produced by complex coacervation using gum
Arabic and gelatin as the wall materials. Comparing the EE% of limonene formulations 6 and 12,
in which only the type of the hardening agent was different and all the other formulation factors
were kept the same, it was found that tannic acid resulted in a higher encapsulation efficiency
(EE% of formulation 6=90.4%) that sodium tripolyphosphate (EE% of formulation 12= 85.3%).
This suggests that tannic acid has higher ability to cross-link with the microcapsules walls than
sodium tripolyphosphate. Additionally, tannic acid did not result in the precipitation around the
microcapsules that could be seen in the optical microscopy images of formulation 12 (Figure
4.7.B).
Increasing the amount of tannic acid from 0.2 g to 0.4 g in formulations 6 and 8, and keeping the
amounts of all other ingredients constant, resulted in the increase of EE% from 90.4% to 97.3%.
This is in line what was reported by Devi et al13 who observed an increase in the EE% from
42.6% to 71.6% when the amount of tannic acid increased from 0.2 to 0.8 mmol, and explained
that the increase in the EE% that occur by increasing the amount of the hardening agent is due to
the presence of more cross-linkable groups able to form more covalent bonding with the
polymers of the wall materials of the microcapsules, and thus making them have higher core
material retention ability.
4.3.2. Optical microscopy
It was observed from the optical microscope images of the formulations that the type of the
emulsifier used had an influence on the dispersion of the microcapsules and their morphology.
Formulations obtained by the emulsifier Tween 20 (HLB=16.5)24 encountered formation of
aggregates of the microcapsules which were mononuclear (Figure 4.4.A). The degree of
aggregation increased when Tergitol (HLB= 13.3)24 was used instead of Tween 20. Tergitol also
produced mononuclear microcapsules but with smaller particle size (Figure 4.4.B). Formulation
3 that was produced with Tween 20 and using chitosan solely as the wall material (without
adding gum Arabic) also had bunches-of-grapes-like aggregation (Figure 4.4.C), and had bigger
size of microcapsules than formulation 1.
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Figure 4.4 Optical microscope images of formulations: A) 1 (Tween 20), B) 2 (Tergitol) and C)
3 (Tween 20 and no gum Arabic). Images on the left show the emulsions and on the right side
are the formulations after adding the hardening agent sodium TPP without sample centrifugation.
Magnification: A) 200 x, B) 200 x and C) 400 x.
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The appearance of this aggregation in formulation 3 indicated that the presence of gum Arabic in
formulation 1 contributed to a better dispersion of the particles in the emulsion than in 3.
Moreover, the absence of gum Arabic resulted in unstable formulation and the appearance of oil
drops on the surface after 2 months. Gum Arabic has been reported in the literature to be highly
beneficial in the stabilization of oil-in-water emulsions and preventing the flocculation of
droplets during the storage at room temperatures; because of its ability to be adsorbed at the
droplet surface.25,26 It could be noticed in the optical microscope images of the formulation 1, 2
and 3, in which sodium TPP was used as hardening agent, the presence of a dark patches
probably of polymer precipitation or gelation between sodium TPP and excess chitosan dissolved
in the medium. The same dark precipitation was also observed when chitosan amount was
reduced from 2g to 0.5g (formulation 11) and another emulsifier was used. However, this
precipitation was removed by centrifugation in some preparations which allowed the
measurement of EE%.
All the formulations that were prepared with PGPR are rounded with polynuclear morphology
(Figure 4.5). PGPR is a hydrophobic emulsifier (HLB=2-4), and its use to form polynuclear
complex coacervate microcapsules through (w/o) or (w/o/w) emulsions has been reported in the
literature.27-29 Polynuclear microcapsules are known to grant more protection for the
encapsulated core material.29 Formulations prepared with Span 85 emulsifier (HLB=1.8) have
shown mononuclear morphology and good dispersion without any aggregation (Figure 4.6).
Moreover, the use of tannic acid as the hardening agent in these preparations resulted in the
highest EE% values compared with other formulations. Nevertheless, when sodium TTP was
used as the hardening agent instead of the tannic acid and Span 85 was kept as the surfactant
(formulation 11), the dark patches of polymer precipitation appeared again (Figure 4.7.A.). It
also appeared when sodium TTP was added to an emulsion obtained with PGR in formulation
12, (Figure 4.7.B). It was observed that sodium TPP resulted in the aggregation of the
microcapsules prepared with Span 85, which previously had good dispersion. Therefore, the
hardening agent also seems to have a big influence on the dispersion of the final microcapsules;
not just the emulsifier. Tannic acid was examined with formulations prepared with Tween 20 and
Tween 80 (HLB=15) and appeared to be incompatible with these emulsifiers since it resulted in
the flocculation of the microcapsules as shown in Figure 4.8.
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Figure 4.5 Optical microscope images of vanillin and limonene microcapsules of formulations
prepared with PGPR: A) 4, B) 5, C) 6 and D) 7. Magnification: A) 200 x, B) 200 x, C) 200 x and
D) 200 x.

Figure 4.6 Optical microscope images of limonene and vanillin microcapsules of formulations:
A) 9 and B) 13, in which Span 85 was used as the emulsifier. Magnification: A) 400 x and B)
400 x.
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Figure 4.7 Optical microscope images of limonene microcapsules of formulations: A) 11 and B)
12; prepared with Span 85 and PGPR, respectively, using sodium TPP as the hardening agent.
Magnification: A) 100 x and B) 100 x.

Figure 4.8 Optical microscope images of vanillin microcapsules of formulations: A) 14 and B)
15; prepared with Tween20 and Tween 80, respectively, using tannic acid as the hardening
agent, in same amounts. Magnification: A) 100 x and B) 100 x.

4.3.3. Particle size
It was observed that the type of the emulsifier greatly influenced the size of the microcapsules.
Tergitol resulted in very small sized microcapsules, Tween 20 and Span 85 produced medium
sized microcapsules and PGPR produced microcapsules with larger sizes than the formers. Table
4.2 lists the mean diameter of the formulations that showed good dispersion. The particle size
distribution was also affected by the core-wall ratio. In the present study, it was noticed that
keeping the amount of wall materials constant and increasing the amount of oil used (from 1 to
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4.5 g) resulted in a significant increase in the mean diameter of the microcapsules which were
prepared with the PGPR (Vanillin formulations 4 and 5 and limonene formulation 6 and 7).
However, a very slight increase was noticed for the mononuclear microcapsules when Span 85
was used (Formulations 9 and 10). The increase in the size of the microcapsules with increasing
the core-wall ratio has been reported in the literature in preparations of microcapsules by
complex coacervation.19,20,29 Dong et al.,30 stated that concerning the multinuclear microcapsules,
the increase in the ratio of core to wall material results in an increase in the amount of emulsion
droplets available in the suspension during the preparation, which subsequently forms larger
spherical coacervate polynuclear microcapsules.
It was also notable that increasing the amount of tannic acid from 0.2 g to 0.4 g (in formulation 6
and 8) resulted in smaller size of microcapsules. This result is consistent with the findings
obtained in the literature.12,31 This may be due to the fact that the availability of more tannic acid
results in an increased degree of cross-linking with the wall materials and consequently makes
the wall more compact and with smaller sizes.
Table 4.2 Mean diameters of produced microcapsules.
Mean diameter
Formulation
(µm)
1
11.2
2
4.1
3
(-)*
4
15.7
5
38.2
6
18.4
7
39.0
8
10.9
9
12.9
10
11.1
11
(-)*
12
35.4
13
10.4
14
(-)*
15
(-)*
(-)* Particle size of these formulations was not measured since they did not have good dispersion
or did not seem stable.
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4.4. Conclusion
Here, the production of chitosan/gum Arabic microcapsules loaded with vanillin or limonene
was successfully achieved by the complex coacervation method. The EE% value ranged from to
62 to 100%, and was shown to be about 30% when gum Arabic was not included. The process
parameters involved the examination of various emulsifiers with significant difference in their
HLB values. Span 85 emulsifier resulted in the highest values of vanillin and limonene
encapsulation, followed by PGPR and then Tween 20 (Span 85> PGPR> Tween 20). The type of
the emulsifier also affected the morphological characteristics of the produced microcapsules; as
Span 85 and Tween 20 resulted in the formation of mononuclear microcapsules whereas PGPR
produced multinucleated particles. Two green hardening agents; sodium TPP and tannic acid
were used separately to cross-link with the microcapsules shell materials. The type and amount
of the hardening agent was found to affect the size and EE% as well as the dispersion of the
particles in the final product. Formulations in which tannic acid was used as the hardening agent
acquired higher EE% values than those which have been treated with sodium TPP.
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Appendix 4.1: Particle size distribution charts of formulation 2.

Figure 4.a Particle size distribution of microcapsules of formulation 2 in volume and in number.
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Appendix 4.2: Calibration Curves for GC-FID Analysis
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Figure 4.b Calibration curve of standard limonene.
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Figure 4.c Calibration curve of standard vanillin.
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Chapter 5: Release of Active Agents
5.1. Introduction
The controlled release of the active agents from the microcapsules intended for textile
applications is crucial to be investigated. The release pattern should provide a slow release from
the fabric microcapsules to the skin without overdosing, and at the same time maintaining a
durable effect.1 In fact, the longer the time the active agent can be retained within the core of the
microcapsules, the longer the shelf-life of the product/fabric would be.2 The characteristics of the
polymers of the microcapsule wall, such as its type, thickness, swellability, degree of hardening,
mechanical strength, and interactions between the wall polymers and the active agent all affect
the diffusion, and hence, the release rate of the core material.3,4
The controlled release based on diffusion processes can be described mathematically by release
kinetics equations. The most frequently discussed release rate models in literature are the zero
order, first order and square root order systems (Figure 5.1). The zero order kinetics involves the
release of the core material at a constant rate over time until total depletion.2,5 The zero release
can be expressed by the following simple equation:6
Mt ∕M0= K0t

(5.1)

where Mt is the amount of the core material/drug released at time t, M0 is the initial amount of
the core material/drug in the solution and K0 is the zero order release constant. The plot of the
zero release kinetics shows the percentage of cumulative release of core material/drug versus
time.
In the first order kinetics (Equation (5.2)),7 the release of the core material is relatively faster in
the beginning, and then decreases with time.2 This kinetic model implies that the change in the
concentration of the released core material/drug with time is dependent on the concentration.
Mt ∕M0= 1-e-kt

(5.2)

The release profile in the square root order kinetics (Higuchi model) exhibits a behavior between
the zero and first order models.2 The Higuchi diffusion model (Equation (5.3)) relates the
concentration of the core material or drug released to the square root of time as follows:
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Mt/M0= kH t½

(5.3)

where Mt/M0 represents the fraction of the cumulative amount of the encapsulated material
released in time t and kH is the Higuchi rate constant.8

Figure 5.1 Graphical representation of the cumulative release of core material as a function of
time. Adapted from Ref 2.
The Higuchi model was first developed to relate the release of a drug from an ointment, but later
it has been used to study the pseudo-steady diffusion of solid drugs from granular and
homogenous matrices.9 The Higuchi model assumes that no interactions occur between the drug
and the matrix, and that the diffusion coefficient is constant.9,10
The Korsmeyer-Peppas release model was originally developed to describe the release of a drug
molecule from a polymeric system. According to Korsmeyer et al., the release rate can be
represented mathematically by the following equation:10
Mt/M∞= Kk. tn

(5.4)

where Mt and M∞ are the cumulative amounts of the drug in the release solution at time t and
infinity, respectively, Kk is the release rate constant, and n is the diffusional exponent that
describes the obtained release mechanism.11
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The Korsmeyer-Pepppas equation is also called the “power law”; as the equation suggests that
the fractional release of core material/drug is exponentially related to time, and the value of
diffusional exponent (n) indicates the diffusional release mechanism of the core agent/drug from
the polymer as shown in Table 5.1.12,13
Table 5.1 The indicative values of the release exponent “n” of Korsmeyer-Peppas equation and
the related release mechanism of the core material/drug from polymers of different geometries.
Adapted from Ref. 12 and 13.

In this chapter, limonene and vanillin microcapsules were prepared by complex coacervation
method. Characterization of the produced microcapsules, regarding the size, morphology and
encapsulation efficiency was evaluated. The cumulative release profiles and the release kinetics
of the core materials were investigated.

5.2. Materials and methods
5.2.1. Materials
Chitosan (Degree of deacetylation 88-95%) and gum Arabic were used as wall materials, and
were purchased from BioLog Biotechnologie Und Logistik (Germany), and Sigma Aldrich,
respectively. The molecular weight range of the chitosan used in all the formulations was
between 80,000 and 200,000 Da as claimed by the manufacturer. Vanillin and limonene were
separately used as the active agents, and were purchased from Sigma Aldrich. Three different
emulsifiers were used Tween 20, Span 85 and Polyglycerol polyricinoleate (PGPR 4150). Tween
20 and Span 85 were supplied by Sigma Aldrich, and PGPR was obtained as a gift from
Palsgaard®, Denmark. Pure corn oil was purchased from Sigma Aldrich. Sodium
tripolyphosphate (TPP) (Sigma Aldrich) and tannic acid (Merck) were used individually as
hardening agents in different preparations. n-Hexane was used a washing reagent for the
microcapsules and was supplied by Carlo Erba Reagents.
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5.2.2. Microcapsules preparation
Three release studies were conducted, each with two formulations produced by changing the
amount of the wall material used, type of the emulsifier, and the hardening agent. The amounts
and different types of materials used in each formulation are mentioned in each study. Vanillin
and limonene formulations were produced independently by the complex coacervation method
according to the general procedure detailed in Chapter 3 (Sections 3.2.1.1 and 3.2.1.2).
5.2.3. Characterization of Microcapsules
The morphology of the prepared microcapsules was examined by optical microscopy and the
mean diameter of each formulation was determined by laser diffraction particle size analysis.
The encapsulation efficiency of microcapsules was determined by quantifying the nonencapsulated core material with GC-FID analysis and calculating the masses of the encapsulated
active agents as reported previously in Chapter 3 (Section 3.2.2.4).
The GC-FID injected samples were prepared by taking 2 ml from the whole formulation and
then mixing them with a particular volume of n-hexane, followed by centrifugation at 3000 rpm
for 5 minutes. This was performed to extract the non-encapsulated vanillin or limonene from the
medium. The supernatant was then collected, filtered through 0.2 µm pore size polypropylene
filter and a volume of 0.1 µL was injected in the GC.
The encapsulation efficiency (EE %) was calculated as the difference between the total mass of
the core material initially used for each preparation, and the non-encapsulated mass using the
following equation:
EE%= mass (total) - mass (non-encapsulated) x 100
mass (total)

(5.5)

where mass (total) is the mass of the loaded core material (g), and mass (non-encapsulated) is the
mass of the non-encapsulated core material (g). The masses of the non-encapsulated active
principles were calculated from the formula (mass= V. C); where V is the volume of the
microcapsules suspension and C is the concentration of the non-encapsulated core materials,
obtained from the corresponding areas of the chromatograms that were quantified by the
standard calibration curve. All measurements were done in triplicates.
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5.2.4. Release studies
In this chapter, three release studies are discussed. These studies examined the effects of varying
some factors during the preparation of the microcapsules, and investigating the influence of these
changes on the release behavior of vanillin and limonene.
Release Study 1: Effect of changing the concentration of the wall materials
Here we examined the effect of decreasing the concentration of chitosan and gum Arabic on the
release rate of limonene from the microcapsules. Table 5.2 summarizes the preparation
conditions for the two formulations A and B that were involved in this study.
Table 5.2 The chemical composition of formulations A and B.
Formulation A

Formulation B

Emulsifier
Mass of emulsifier
Limonene (Core)

Tween® 20
2.58 g
32 g

Tween® 20
2.58 g
32 g

Chitosan

1g

0.5 g

Gum Arabic
Hardening agent

2g
Sodium TPP (0.5 g)

1g
Sodium TPP (0.25 g)

Release Study 2: Effect of changing the type of emulsifier on the release of limonene
In this study, two different emulsifiers Span 85 and PGPR were used in the preparation of two
formulations; C and D. Both emulsifiers were used in same amounts as shown in Table 5.3.
Table 5.3 The chemical systems of formulations C and D.
Formulation C

Formulation D

Emulsifier
Mass of emulsifier
Limonene (Core)

Span 85
0.35 g
1g

PGPR
0.35 g
1g

Chitosan

0.5 g

0.5 g

Gum Arabic

1g

1g

Tannic acid

0.2 g/ 2 ml deionized water

0.2 g/ 2 ml deionized water
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Release Study 3: Effect of changing the type of the core material
In this study vanillin was used as the encapsulated core material instead of limonene. As
indicated in chapter 3, (section 3.2.1), vanillin crystals were first dissolved in corn oil to prepare
the emulsion before initiating the complex coacervation process. Table 5.4 shows the chemical
system in formulations E. This formulation is comparable to formulation D in the second release
study, where limonene was encapsulated using the same emulsifier.
Table 5.4 The chemical composition of formulation E.
Formulation E
Emulsifier
PGPR
Mass of emulsifier
0.6 g
Corn oil
4.5 g
Vanillin (Core)
0.12 g
Chitosan
0.5 g
Gum Arabic
1g
Tannic acid
0.2 g/ 2 ml deionized water

5.2.4.1. Cumulative release profiles
The release studies of the active agents from the microcapsules were conducted directly after the
preparation of each formulation. In each study, equal volumes of microcapsules suspensions
were washed with deionized water and n-hexane (¾ of the volume of the microcapsules
suspension) in order to remove all the non-encapsulated core material from the microcapsules
surrounding phase, and then placed in a sealed glass container that contained a fresh 30 ml of
hexane. Samples were incubated at a constant temperature (50ºC for the first release study and
37ºC during the second and third release studies) and mild continuous stirring at 100 rpm, for a
specific duration according to each study (7-40 days). At predetermined time intervals, samples
were taken out of the incubating chamber; certain volume of hexane (2 ml) in the supernatant
was filtered through 0.2 µm pore size polypropylene filter and placed in a sealed vial for GC-FID
analysis. The volume of each GC-FID injected sample was 0.1μL. Injections were carried out in
triplicates and the mean value of the peak area corresponding to the active agent (either limonene
or vanillin) in each acquired chromatogram was determined. The average areas were then
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quantified to the corresponding concentration in view of the standard calibration curve of the
core material being measured. Then the masses of the released active agents were calculated
from the formula (mass= volume x concentration). The cumulative release from the
microcapsules suspension for each time interval was calculated from the following equation:14
Cumulative Release % (CR %) = Mx / M0 X 100

(5.6)

Where Mx is the mass of released limonene or vanillin at a certain time interval and M0 is the
initial mass of limonene or vanillin present in the microcapsules.
5.2.4.2. Kinetic analysis of the release profiles
The obtained cumulative release data were kinetically examined to determine the release order of
limonene and vanillin from the microcapsules using Excel, Microsoft Office 2010. Four release
kinetics models were used to assess and fit the obtained release profiles of limonene and vanillin
microcapsules; the zero-order model, the first order model, the Higuchi model and the
Korsmeyer-Pepppas model. Thereafter, upon comparison of the linear regressions of the four
models for a given release profile, the kinetic model with higher regression coefficient (r2) was
considered as the most appropriate release kinetic model for that release profile. This method is
frequently used in the literature to determine the kinetic model of the in-vitro drug release and
active principles from different dosage systems, and nano- and microcapsules.15-20

5.3. Results and discussion
5.3.1 Optical Microscopy
The morphology of the microcapsules of the three release studies has been examined by means
of optical microscopy. Figures 5.2, 5.3 and 5.4 show the micrographic images of the
microcapsules of the first, second and third release studies, respectively. It was observed that the
microcapsules in all the formulations are spherical. Limonene microcapsules in formulations A
and B of release study 1 are mononuclear and have a regular and smooth appearance. Images (a)
and (b) in Figure 5.2 show that the microcapsules of formulation A have a larger size than those
of formulation B (images (c) and (d) in Figure 5.2). The appearance of the limonene
microcapsules in formulation D (images (c) and (d) in Figure 5.3) would suggest that they are
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polynuclear in nature. The same morphology was also observed for the vanillin microcapsules in
formulation E (images (a) and (b) in Figure 5.4). However, the apparent polynuclear vanillin
microcapsules look denser than the limonene ones which were prepared using the same
emulsifier; this might be due to the different nature, including the rheological properties and
densities between limonene and corn oil (than was used to dissolve vanillin) which comprise the
core of the microcapsules and also the relatively higher amount of vanillin and corn oil used than
the limonene in formulation D.
5.3.2 Particle Size Evaluation
Particle size distributions in both, volume and number of the microcapsules of the release studies
1, 2 and 3 are shown in Figures 5.5, 5.6, and 5.7, respectively. The mean diameter values of the
six formulations in the three studies are given in Table 5.5.
For formulation A (Figure 5.5 (a)), a bimodal distribution was observed with a mean particle size
around 8 μm. A bimodal distribution was also seen in the particle size distribution of formulation
B (Figure 5.5 (c)), with a mean particle size of 3.8 μm. This shows that the particle size increased
by doubling the concentration of the wall material in formulation A, and thus follows the same
trend observed in previous reports in the literature21,22 where it was concluded that the size of the
microcapsules prepared by the complex coacervation method increases by increasing the wall
material concentration.
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Figure 5.2 (a) and (b) Optical microscopy images of limonene microcapsules of formulation A,
(c) and (d) of formulation B after hardening and centrifugation. Magnification of images: (a)
400x; (b) 1000x; (c) 400x and (d) 1000x.
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Figure 5.3 (a) and (b) Optical microscopy images of limonene microcapsules solution of
formulation C (formed with Span 85), (c) and (d) of formulation D (forms with PGPR) after
hardening and centrifugation. Magnification of images: (a) 400x; (b) 1000x; (c) 200x and (d)
400x.
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Figure 5.4 (a) and (b) Optical microscopy images of vanillin microcapsules of formulation E
(with PGPR) after hardening and centrifugation. Magnification of images: (a) 100x and (b) 200x.
The use of different emulsifiers in the second release study showed dissimilarities in particle size
distributions, although the other chemical system and preparation conditions were the same
within the study. It was observed that the emulsifier PGPR which was used in the preparation of
formulations D has led to the formation of microcapsules not just with a different morphology,
but also with a greater mean diameter than those obtained by the Span 85 emulsifier (formulation
C).
Table 5.5 Mean diameters of produced microcapsules.
Release Study Formulation Volume mean diameter (µm)
1

2
3

A

8.0

B

3.8

C

11.1

D

18.4

E

38.2
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5.3.3. Scanning Electron Microscope
The SEM micrographs of formulation B (Figure 5.9 (1) and (2)) show that the fabricated
microcapsules have spherical shape and are covered with a thick layer. This might reveal that
some of the wall materials could not deposit completely on the core material during the
preparation process, but eventually deposited on the surface of the formed microcapsules later
covering it with this layer. Similar images were observed by Yang et al., who reported that such
“conglutination” in appearance is due to the use of high viscosity chitosan.23
5.3.4. Encapsulation efficiency of microcapsules
In general, the microencapsulation of hydrophobic materials by the complex coacervation
method results in high encapsulation efficiency.24 Table 5.6 compares the percentage of the core
material (limonene or vanillin) entrapped in the microcapsules in the six formulations.
In the first release study, the difference in the EE% is related to the difference in the
concentration of the wall material, while in the second and third release studies, the
encapsulation efficiency was influenced by the type of the emulsifier used.
Decreasing the concentration of the wall materials in formulation B to half the amount of
formulation A resulted in the reduction of the EE% from 98.4% to 93.2%. It is worth noting that
previous studies reported that encapsulation efficiency increases with increasing the
concentration of the polymers. A possible explanation of this is that higher concentrations of the
dispersion phase result in higher viscosity and enhance faster precipitation of the polymer on the
oil phase, and thus delays its diffusion from the microcapsules to the outer phase.25
In the encapsulation efficiencies of the second release study; formulations C (98.6%) and D
(90.4%), it could be observed that changing the type of emulsifier had an influence on how much
core material could be entrapped. This could also be related to the difference in the morphology
of the formed microcapsules (mononuclear versus multinuclear).
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(a)

(b)
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(c)

(d)
Figure 5.6 Particle size distribution of limonene microcapsules of the first release study:
formulation A; distribution in volume (a) and in number (b); and formulation B; distribution in
volume (c) and in number (d).
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(a)

(b)
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(c)

(d)
Figure 5.7 Particle size distribution of limonene microcapsules of the second release study:
formulation C; distribution in volume (a) and in number (b); and formulation D; distribution in
volume (c) and in number (d)
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(a)

(b)
Figure 5.8 Particle size distribution of vanillin microcapsules of the third release study:
formulation E; distribution in volume (a) and in number (b).
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Figure 5.9 SEM micrographs of limonene microcapsules of formulation B after freeze- drying.
The effect of the emulsifier on the characterization properties of microcapsules is often
mentioned in the literature. For example recently it was reported the effect of the HLB
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(hydrophilic-lipophilic balance) of the surfactants Tween 20, Tween 80, Tergitol 15-S-9, Span
85, and their combinations on the encapsulation efficiency of thymol oil/PLA microcapsules
prepared by simple coacervation.25 The HLB range of the emulsifiers used in that study was
between 11 and 16.5 and the highest EE% obtained was 65 % when Tergitol 15-S-9 (HLB=13.3)
was used. The influence of the HLB value on the encapsulation efficiency of microcapsules
obtained by complex coacervation was investigated by Rabisková et al.,26 where they reported
that emulsifiers of HLB values between 1.8 and 6.7 resulted in encapsulation efficiencies, while
using an emulsifier with an HLB value of 9.6 caused a significant decrease in the amount of the
encapsulated oil. Higher HLB values of 10 and 15 failed to incorporate the oil inside the
microcapsules. This explains the high EE % obtained with the lipophilic surfactants PGPR
(HLB= 2-4)27 and Span 85 (HLB=1.8).26
Table 5.6 Encapsulation efficiencies percentages of the formulations used in the three release
studies.

Formulation

Core
material

A
B
C
D
E

Limonene
Limonene
Limonene
Limonene
Vanillin

Emulsifier

Total
mass
(g)

Nonencapsulated
mass (g)

Encapsulated
mass (g)

EE%

Tween 20
Tween 20
Span 85
PGPR
PGPR

32.5
32.5
1
1
0.12

0.5
2.18
0.014
0.096
0.0058

32
30.32
0.986
0.904
0.1142

98.4
93.0
98.6
90.4
95.2

5.3.5 Release Studies
5.3.5.1. Effect of changing concentration of the wall materials
The release profiles of microcapsules in formulations A and B were investigated throughout the
course of 30 and 40 days, respectively. It was notable from the cumulative release graphs (Figure
5.10 and 5.11) of both formulations that the release rate was very slow and prolonged, and did
not follow the expected biphasic release behavior which is usually obtained from microcapsules
produced by the complex coacervation method. In formulation A, approximately 0.61% of the
total encapsulated limonene was released after incubating the microcapsules suspension for 30
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days (at 50º C and 180 rpm). For formulation B, it was observed that a mass of only 0.443 g was
released, which corresponds to 1.5% of the initial encapsulated mass of 30.32 g.
This difference between the amounts of limonene released in the two formulations is attributed to
the difference in the thickness of the microcapsules wall. Lower concentration of wall materials
results in decreasing the microcapsules membrane, making the diffusion of the core material
easier and hence, gives higher release rate.28 Furthermore, the smaller particle size of the
microcapsules of formulation B also contributed to the faster percentage release of the internal
phase; the diffusional path length for the oil becomes smaller and the contact surface area
between the microcapsules and the dissolution medium becomes larger.29
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Figure 5.10 Cumulative release profile of limonene in formulation A.
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Figure 5.11 Cumulative release profile of limonene in formulation B.
The release curves obtained from this study which demonstrated a very slow release behavior,
along with the SEM images (Figure 5.9) suggest that the release of limonene was hindered by the
layer that appeared to surround the microcapsules. This layer might be due to the high viscosity
of chitosan as discussed earlier. It might be also due to the gelation caused by the hardening
agent sodium TPP or due to excess limonene oil that might have leaked with time.
5.3.5.2. Effect of the type of emulsifier on the release pattern of limonene
The release manner of limonene from microcapsules in formulations C and D varied with the
type of the emulsifier used in each formulation. Both formulations exhibited biphasic release
behavior; one that is characterized initially by a burst release effect that is followed by a plateau
of gradual sustained release.30 Nevertheless, the initial burst release effect took a longer time in
formulation C (Figure 5.12) than in D (Figure 5.13). The burst release effect is described as a
high initial delivery of the encapsulated active agent before the release profile reaches a steady
rate.23,30 The reason of this fast initial release phase might be due to the distribution of some of
the core material on the surface of microcapsules. Once this adsorbed surface oil is released, the
release pattern becomes stable and the remaining oil is then liberated mainly by penetration
through the microcapsules wall.23,31 The burst effect may also occur because of the low
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molecular weight of the active agent and as a result of the high osmotic pressure and difference
in concentration gradient.30 Although the initial burst effect might contribute to the reduction of
the lifetime of the product, it is desired in specific applications, such as encapsulated flavors,
wound treatment, targeted delivery (where a targeted burst release is required) and pulsatile
release.32
It has been previously reported that the multinuclear microcapsules have better controlled release
behavior than the mononuclear microcapsules, which makes them more favorable in the
applications that require prolonged release.22 By analyzing the curves of limonene release in our
study, it could be observed that the release was initially faster in formulation D than in C.
However, the stable sustained release phase started earlier (after almost 24 hours) in formulation
D (Figure 5.13); whereby 43% of the incorporated limonene was released. The same phase
started in formulation C (Figure 5.12) after 120 hours (5 days) where about 74% of the
encapsulated limonene was released. It was notable that after incubating both formulations for 7
days (168 hours), at 37 ºC and 100 rpm, the overall cumulative release for the mononuclear
microcapsules was about 75%, whereas it was 52% for the polynuclear microcapsules. In this
context, it could be concluded that the release rate is lower in the polynuclear microcapsules than
in the case of mononuclear microcapsules. These results are in agreement with those described
by Jégat et al.; who used different stirring speed to produce mononuclear and polynuclear
microcapsules, and reported a lower release rate for the polynuclear microcapsules than the
mononuclear microcapsules.33
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Figure 5.12 Cumulative release profile of limonene in formulation C (with Span 85).

Figure 5.13 Cumulative release profile of limonene in formulation D (PGPR).
90

5.3.5.3 Effect of the type of the core material
This study was performed to investigate the release profile of vanillin from the chitosan/gum
Arabic microcapsules (Formulation E) in which PGPR was used as the emulsifiers. It was found
that there was a change in the morphology of vanillin microcapsules of formulation E after 10
days of incubating the sample at 37ºC and stirring at 100 rpm to study the release. Figure 5.14
shows the alteration that occurred to the appearance of the internal phase of the multinuclear
microcapsules by the end of the study. There seemed to be a collapse/disintegration in the
encapsulated core droplets inside the main membrane of each microcapsule.

Figure 5.14 Optical microscope images of vanillin microcapsules of formulation E: (a) before
and (b) after10 days after incubating at 37ºC ± 1 and 100 rpm during the third release study.
It could be observed from the cumulative release profile of vanillin in formulation E that it also
demonstrated a biphasic release pattern but is much prolonged than the limonene released from
the polynuclear microcapsules in formulation D (prepared with the same emulsifier and have
similar morphologies). The release plot (Figure 5.15) shows a high initial release followed by a
plateau. However, in this formulation the plateau was attained after about 48 hours; whereby
approximately only 16% of the total encapsulated vanillin was released. This result is relatively
lower than what was observed in the case of the release profile of limonene in formulation D.
Furthermore, it was observed that after 7 days (168 hours), the total cumulative % of vanillin
released was about 19.4 % of the total amount of encapsulated vanillin, unlike limonene
formulation D in which 52 % of the total encapsulated limonene was released within the first 7
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days of incubating at the same conditions (37ºC and 100 rpm). This slower release rate behavior
is probably due to the difference in the chemical structure of vanillin and limonene, and also
their ability to diffuse through the wall polymers, added to that the fact that vanillin, unlike
limonene, which was dissolved formerly in corn oil and shares the microcapsules core with it,
this have might participated in the slow transport of vanillin out of the microcapsules shell. The
results obtained here are similar to the slow and sustained release profile of vanillin that was
reported by Dalmolin et al.,34 who used poly-lactic acid nanoparticles to encapsulate vanillin and
obtained a biphasic slow pattern with 20% cumulative vanillin release after 120 hours. In the
same study, the authors mentioned the importance of the biphasic release in pharmaceutical
applications; where the initial burst effect is needed in reaching suitable plasma concentration
and triggering the therapeutic onset, whilst the plateau phase is important in maintaining a stable
drug concentration for long duration. Prolonged sustained release of vanillin aroma from
polysaccharide polymeric hydrogels was also described in the literature as desirable in the
perspective of controlled release applications.35
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Figure 5.15 Cumulative release profile of vanillin in formulation E (PGPR).
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5.3.5.4 Kinetic analysis of the release profiles
The data obtained from the former cumulative release profiles were fitted to the zero-order, the
first-order, the square root of time (Higuchi) and the Korsmeyer-Peppas model equations to
determine the kinetics and the mechanism of limonene and vanillin release from the
microcapsules. Table 5.7 lists the regression coefficients (r2) and the diffusion exponent (n) of
the determinations. The release kinetic of formulation A suggests a zero-order release; since it
has shown a higher r2 value than the other two models. However, it was found that the release
data of formulations B and C could be best fitted into the first order release kinetics. The highest
coefficient for the release data of formulations D and E (who have the same morphology) was
observed for the Higuchi release, but it was also noticed that the values of regression coefficients
of formulation D for all of the three models were relatively lower than the coefficients of
formulations A, B, C and E. Probably the release data of formulation D would be better fitted in
a different kinetic model.
Table 5.7 Correlation Coefficient (r2) of release kinetics and diffusion exponent (n) of active
agents from the chitosan/gum Arabic microcapsules.
Higuchi

Formulation

Zero Order (r2)

First Order (r2)

A

0.8903

0.8899

0.7233

≈0.45

B

0.9866

0.9869

0.9443

≈0.59

C

0.9260

0.9547

0.9250

≈ 0.78

D

0.7828

0.8331

0.8697

≈ 0.45

E

0.8244

0.8401

0.9733

≈ 0.09 (< 0.43)

(r2)

Korsmeyer-Peppas (n)

Despite the differences in their release profiles, the (n) value “release exponent” of the
Korsmeyer–Peppas equation plot for the formulations A, B, C and D fell between (0.43 and
0.85) which indicates that the mechanism of limonene release in these formulations most
probably follows an anomalous transport pattern, one that is controlled by non-Fickian diffusion
and involves a combination of the diffusion and erosion mechanisms.36 This is consistent with
the fact that the diffusion of materials through polymers is not always controlled by the standard
Fickian diffusion model.37 However, the release exponent value (n) for formulation E was found
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to be about 0.09 (i.e., ≤ 0.43); which suggests that the release of vanillin from the microcapsules
was controlled by diffusion. This value is similar for the one reported in the literature for the
vanillin release form poly-lactic acid nanoparticles;34 and thus, the adopted controlling release
mechanism might be related to the type and nature of the core material in this case, i.e., vanillin.

5.4. Conclusion
In this chapter, chitosan/gum Arabic limonene and vanillin microcapsules were prepared by the
complex coacervation method. The encapsulation efficiency ranged between 90.4% and 100%.
Optical microscopy confirmed the spherical shape of the microcapsules. However, the
morphology and the particle size of the microcapsules varied remarkably according to the
chemical system of each formulation. The mean diameter of microcapsules based on volume
distribution ranged from 3.8 µm to 38 µm. Tween 20 and Span 85 emulsifiers produced
mononuclear microcapsules, while PGPR gave rise to multinuclear ones. Notably, the release
profiles of the active agents from the microcapsules have shown different release characteristics
and were dependent on the concentration of the encapsulating polymers, the nature of the
incorporated core material and the morphology of the microcapsules. Additionally, they
demonstrated a considerable controlled release patterns that would make their use appropriate for
many applications.
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Chapter 6: Impregnation of Microcapsules on Textiles and Evaluation of the
Antimicrobial Activity
6.1. Introduction
Developing innovative textiles with added-value properties is a production engineering challenge
that enhances market competitiveness and growth.1 Microencapsulation introduces new durable
properties to fabrics through the incorporation of active compounds with various functions, such
as antimicrobials, dyes, phase change materials, insect repellents, flame retardants, thermo- and
photo-chromatic finishes and fragrances. 2,3
The process of fixing the microcapsules onto textile substrates is critical in ensuring durability,
wash-ability and the effectiveness of the added value to the fabric. The commonly known
industrial methods that are used to apply microcapsules to fabrics are the spraying,
padding/curing, bath exhaustion and coating. The bath exhaustion method is commonly applied
when a chemical reaction between the fabric and microcapsules is required.4 These adhesion
methods involve the use of two main groups of binders; polymeric resins, which possess a filmforming ability, and polyfunctional crosslinking agents. The first group includes polymers, such
as carboxymethyl cellulose, silicon, acrylate resin, polyether polyurethane and polyvinyl acetate,
while the second group includes the chemical cross-linkers, which can be subdivided into
formaldehyde based cross-linkers, e.g., formaldehyde and glutaraldehyde, and non-formaldehyde
based cross-linkers, such as polycarboxylic acids, such as citric acid, succinic acid and 1,2,3,4butanetetracarboxylic acid.5,6
Although film-forming binders provide a three dimensional network that strongly adheres
microcapsules to the fabric, they may hinder the release of the encapsulated active agent and
reduce the aroma intensity of the fragrance microcapsules after adhesion on fabrics.5,7 Therefore,
chemical grafting by means of one of the members of the second group is sometimes preferred.
Grafting or crosslinking of microcapsules to cotton fabrics via polycarboxylic acids occurs
covalently through an esterification reaction between the carboxylic groups of the cross-linker
and hydroxyl groups of the cotton cellulose and/or the hydroxyl groups of the polymers of the
shell of the microcapsules (-OH groups of chitosan and gum Arabic). Figure 6.1 and Figure 6.2
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help illustrate this reaction which occurs in the presence of heat and a catalyst. 5,8-10 The reaction
can also be aided by microwave radiation11and ultraviolet radiation.12

Figure 6.1 The cross-linking reaction between chitosan and cellulose of cotton using citric acid.
Adapted from Ref 12.

Figure 6.2 Representation of the proposed grafting reaction of the produced microcapsules on
cotton fabrics. Adapted from Ref 10.
Recently, more attention has been directed towards the production of antibacterial functionalized
textiles for medical and hygienic uses.13,14 Vanillin encapsulated in a polysulfone polymer and
incorporated onto cotton fabrics was reported to provide the fabrics with durable aromatic
properties and antibacterial activity against Staphylococcus aureus.15 Rodrigues and coworkers
used interfacial polymerization technology to encapsulate limonene in polyurethane-urea
microcapsules for the purpose of producing durable fragrant fabrics.16 Sundrarajan also reported
the preparation of limonene/gum Arabic microcapsules by the coacervation method for
antibacterial textile application using citric acid for the grafting reaction. 14,17
This chapter describes the strategy employed to achieve the immobilization of the produced
limonene and vanillin microcapsules on cotton fabrics by using green materials and processes.
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The work aimed at overcoming the effect of extreme thermal treatment on microcapsules during
the drying and curing steps; as the temperature of the linking reaction seemed to greatly
influence the amount and morphology of the microcapsules grafted onto the fabrics. The main
challenge encountered was in reaching a formulation to prepare microcapsules with sufficient
strength to endure the fixation process and thus, maximize their deposition on the fabrics. The
antimicrobial activity of both the free microcapsules (before grafting) and the functionalized
fabrics was investigated respectively by means of the agar diffusion test and the standard test
method under dynamic contact conditions.

6.2. Materials and methods
6.2.1. Materials
Chitosan (Degree of deacetylation 88-95%) and gum Arabic were used as shell-forming
materials, and were purchased from BioLog Biotechnologie Und Logistik (Germany), and Sigma
Aldrich, respectively. Standard 100% cotton fabric was purchased from SDC Enterprises
Limited, UK. Vanillin and limonene, which were separately used as core agents, were purchased
from Sigma Aldrich. Citric acid, sodium hypophosphite and sodium phosphate monobasic
monohydrate were purchased from Sigma Aldrich and were used in the chemical grafting
reaction. Tween 20 and Span 85 were used as emulsifying agents and were supplied from Sigma
Aldrich. Polyglycerol polyricinoleate (PGPR 4150), also used as emulsifier in some preparations,
was a gift from Palsgaard®, Denmark. Pure corn oil was used in the preparation of microcapsules
to dissolve vanillin, and was obtained from Sigma Aldrich. Sodium tripolyphosphate (TPP)
(Sigma Aldrich) and tannic acid (Merck) were used individually as hardening agents in different
preparations. N-hexane was used as the washing medium for the microcapsules and was supplied
by Carlo Erba Reagents. Baypret USV®, a commercial polyurethane binder, supplied from
Bayer, was also used to evaluate the textile impregnation with the produced microcapsules.
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6.2.2. Microcapsules preparation
Vanillin and limonene microcapsules were produced independently by the complex coacervation
technique according to the general procedure described in Chapter 3 (Sections 3.2.1.1 and
3.2.1.2) and Chapter 4 (Section 4.2.2). In order to reach an optimized microcapsules formulation
that could be successfully adhered to cotton fabrics, several trials were conducted by altering the
amount of the core material incorporated, type of the emulsifier, and the hardening agent used.
The amounts and different types of materials used in each formulation are listed in Table 6.1
Table 6.1 Used chemicals and formulations in the preparation of microcapsules.
Core
Amount
of C
GA Emulsifier
Hardening
Formulation
material core material (g) (g)
(g)
agent
Vanillin
0.3g/20ml
Tween 20
1
2
8
corn oil
2.58 g
Sodium TPP
Vanillin
Ratio TPP :
0.3g/20ml
Tween 20
2
0.5 1
Chitosan
corn oil
3.9 g
(1:2)
Tween
20
3*
Limonene 32.5 g
1
2
3.9 g
PGPR
4 **
Limonene 1 g
0.5 1
(0.35 g)
PGPR
5
Limonene 4.5
0.5 1
(0.6 g)
Span 85
6 **
Limonene 1 g
0.5 1
Tannic acid
(0.35 g)
0.2 g/ 2ml
PGPR (0.35
7
Vanillin 0.02g/ 1 g 0.5 1
H2O (10%)
corn oil
g)
PGPR
8 ***
Vanillin 0.12g/4.5
0.5 1
corn oil
(0.6 g)
Span 85
9
Vanillin 0.02g/ 1 g 0.5 1
corn oil
(0.35 g)
*Limonene formulation 3 is formulation A that was investigated in the first release study in
chapter 5.
**Limonene formulations 4 and 6 are formulations D and C which were investigated in the
second release study in chapter 5.
***Vanillin formulation 8 is formulation E which was investigated in the third release study in
chapter 5.
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6.2.3. Fabric treatment with microcapsules
6.2.3.1. Simple coating
This method was discussed in chapter 3, section (3.2.4.1). It involves immersing the cotton
fabrics in a suspension containing the microcapsules without the addition of binders or grafting
agents.
6.2.3.2. Fixation with binder
The method applied was described by Rodrigues et al.16 for the fixation of polyurethane-urea
microcapsules on wool/polyester fabrics at a laboratory scale while simulating the industrial
impregnation conditions. An impregnation bath was prepared as shown in Table 6.2. The cotton
fabrics were immersed in the bath and left for three minutes to allow for the penetration of the
microcapsules and other bath constituents. The treated fabrics were passed through a two rollers
foulard at a pressure of 3 bars and a speed of 3m/minute to squeeze the excess liquid from the
fabric samples. The samples were then dried and cured thermally at the temperatures and time
durations specified in Table 6.2.
Table 6.2 Impregnation conditions with polymeric binder.
Textile type

Cotton lawn fabric

Bath Volume

250 ml

Bath Ingredients
Microcapsules (formulation 1 and 2)

50 g/L

Baypret® USV (polyurethane binder) 50 g/L
Perisoftal® Nano (softener)

10 g/L

Padding by Foulard

3 bar (0.3 MPa)

Drying “Thermofixation”

100ºC-3 minutes

Curing

140ºC -3 minutes
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6.2.3.3. Fixation using citric acid
Citric acid was used as a polycarboxylic acid cross-linker to covalently join the wall materials of
the microcapsules (chitosan and gum Arabic) to the cotton fabrics by ester bonds. The procedure
applied here is based on methods previously reported in the literature,9,10,18 but with some
modifications. Briefly, the test fabrics were firstly immersed in a bath containing the 10 % w/v
microcapsules suspension, 3% w/v citric acid, 1.5 % w/v catalyst (sodium phosphate monobasic
monohydrate ) and thereafter heated at 50ºC for 5 minutes. Fabrics were then washed thoroughly
with deionized water and passed through a 2 roller foulard with 1 bar pressure at a speed of 3
m/min. Subsequently, fixation was achieved by placing the fabric samples in a thermofixation
chamber with circulating air at a temperature of 90ºC for 2 minutes. After drying, the curing
process was investigated at two different temperatures (120ºC and 150ºC for three and two
minutes, respectively) to obtain the maximum number of microcapsules immobilized onto the
fabrics. Table 6.3 summarizes the curing process conditions of different fabric samples. The
fixation reaction was also investigated for samples 5 and 8 using a domestic microwave oven
(MS-2029UW, LG), with an output of 800 Watts for one minute. The wet pick up percentage of
the impregnated samples ranged between 95% and 100% and was determined after passing
through the foulard by the following formula: 16
Wet pick %= mass of impregnation bath taken by the fabric x 100
mass of the dry fabric

(6.1)

Table 6.3 Curing conditions of microcapsules fixation using citric acid as a cross-linker.
Formulation
Curing temp
(ºC)
Curing time
(minutes)

3

4

5

5

6

7

7

8

9

120

120

120

150

120

120

150

120

120

3

3

3

2

3

3

2

3

3

103

6.2.4. Characterization
6.2.4.1. Optical microscopy
The morphology of the microcapsules was analyzed by using a Leica DM 2000 optical
microscope, working in transmission light mode, and equipped with a Leica Application Suite
Interactive Measurement imaging software. Optical microscopy was also used to examine the
impregnated fabrics prior to their examination with SEM.
6.2.4.2. Particle size analysis
The mean particle size and size distribution of the microcapsules suspensions were determined
by means of a Beckman Coulter Laser Diffraction Particle Size Analyzer LS 230.
6.2.4.3. Gas chromatography (GC-FID)
GC-FID was used to determine the encapsulation efficiency of vanillin and limonene
microcapsules. The method was previously reported in Chapter 3 (Section 3.2.2.4). The
encapsulation efficiency (EE %) was determined based on the difference between the total mass
of the core material initially used for each preparation, and the non-encapsulated mass,
calculated according to the following formula:
EE%= mass (total) - mass (non-encapsulated) x 100
mass (total)

(6.1)

where mass (total) is the mass of the loaded core material (g), and mass (non-encapsulated) is the
mass of the non-encapsulated core material (g). The masses of the non-encapsulated active
principles were calculated from the formula (mass= volume x concentration). The concentration
of the non-encapsulated core materials were obtained from the corresponding areas under the
curves of the respective chromatograms.
6.2.4.4. Effect of heat on the morphology of microcapsules
A simple test was done to examine the effect of temperature on the morphology of microcapsules
prior to their chemical grafting onto fabrics. A sample of about one gram of each formulation
was placed on a watch glass and introduced in an oven where they were exposed consecutively
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to temperatures of 50ºC, 120ºC, and 160ºC for 5, 2 and 2 minutes, respectively. Dry samples
were then dispersed in deionized water and examined with the optical microscope to investigate
possible deterioration in microcapsules’ morphology.
6.2.4.5. Scanning electron microscope (SEM)
A high-resolution (Schottky) Environmental Scanning Electron Microscope with X-Ray
Microanalysis and Electron Backscattered Diffraction Analysis: Quanta 400 FEG ESEM/EDAX
Genesis X4M operating at 15.00 kV was used to examine the morphological features of the
microcapsules grafted onto the cotton fabrics.
6.2.4.6. Solid Content Determination
The solid content of the microcapsules was determined according to the European Standard EN
827 method- “Determination of solid content in water based adhesives”. The steps of the test
were previously discussed in detail in Chapter 3, Section 3.2.2.6.
6.2.4.7. Effect of washing on treated fabrics
In order to investigate the effect of washing on the grafted microcapsules and their antibacterial
activity, after drying and curing, some fabric samples were washed with deionized water
containing 2% commercial soap for 15 minutes at 40ºC, rinsed in deionized water, and then
washed with 0.1N acetic acid and re-rinsed with deionized water. Acetic acid was used to
remove any residual unreacted chitosan from the surface of the fabrics. The washing was done
according to methods described in the literature;19,20 and was repeated three times to remove any
excess of polymer (chitosan or gum Arabic) and any unattached microcapsules.
6.2.4.8. FTIR spectroscopy
FTIR spectroscopic assay was used to examine the grafting reaction of the microcapsules on the
cotton fabric. FTIR spectra were collected for the freeze-dried microcapsules, tannic acid, citric
acid, control (untreated) cotton fabric, and the impregnated cotton fabric. The microcapsules
were separated from the original microcapsule suspension by decantation and then freeze-dried
into a powder form prior to the analysis. The analysis was conducted using a Jasco FT/IR-6800
spectrometer, (Jasco Analytical Instruments, USA), equipped with a MIRacle™ Single
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Reflection ATR (attenuated total reflectance ZnSe crystal plate) accessory (PIKE Technologies,
USA) and a TGS (triglycine sulfate) detector. Cosine apodization function was used to suppress
leakage side lobes on the sampled signal. FTIR spectra of 56 scans at a resolution of 4 cm−1 were
collected and averaged to obtain the single-beam background and sample ATR spectra. The
spectra were collected over the spectral range of 4000–500 cm-1 in the Absorbance mode. The
fabrics were used as they are and certain parts were randomly sampled to ensure consistent
analysis and reproducibility. Aliquots of powdered samples (citric acid, tannic acid and limonene
microcapsules) were analyzed without dilution to obtain the corresponding analyte standard
FTIR spectrum using the same ATR accessory.
6.2.5. Evaluation of antibacterial activity
6.2.5.1. Agar diffusion method
This assay was conducted with the limonene and vanillin microcapsules suspensions obtained
from formulations 4 to 9, after washing the microcapsules suspensions with deionized water and
hexane to remove any excess oil or unreacted substances. Staphylococcus aureus (ATCC 19213)
and Escherichia coli (ATCC 10536) were used as the test microorganisms, as representatives for
Gram positive and Gram negative bacteria, respectively. The bacterial inoculums were prepared
by transferring 4 isolated colonies of each type, under aseptic conditions, to separate test tubes
containing nutrient broth that were then incubated at 37ºC for 24 hours. The inoculums were then
diluted by sterilized Ringer solution to a concentration of 0.5 McFarland turbidity, which is
comparable to a bacterial concentration of 1.5–3.0 x 108 CFU/ ml. The concentration of the
bacteria dilutions were also ascertained through UV spectrophotometry by measuring the
absorbance at a wavelength of 625 nm. The absorbance of S. aureus was 0.0938, while E. coli
was 0.0940. The bacterial solutions were then inoculated on the surface of Mueller Hinton Agar
plates, using sterilized cotton swabs, and the plates were allowed to dry. Then, a well of 6 mm
diameter was made in the center of each inoculated plate; the plug was removed, and filled with
100 µl of microcapsules suspension.
The free active agents were also tested separately (not incorporated in microcapsules). The
limonene oil was diluted in dimethyl sulfoxide (DMSO) (7:3 ratio), and the vanillin was
dissolved in corn oil (0.03 g vanillin in 1g of oil). The plates were incubated at 37ºC for 24 h.
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After this period, the diameter of the inhibition zone was measured and incubation maintained
for more 4 days in order to evaluate the possible change in the inhibition zone. The clear zone of
inhibition formed around each hole after the incubation (inhibition halo), indicates an
antimicrobial activity and its diameter is an indication of the inhibitory effect. All of the tests
were done in duplicates.
6.2.5.2. Standard test method under dynamic contact conditions
This test was performed to evaluate the antibacterial activity of the fabrics impregnated with
vanillin and limonene microcapsules. It is based on the American Society for Testing and
Materials standard (ASTM) Designation: E 2149-01 standard method, with a slight modification.
This standard method is originally designed to investigate the ability of samples treated with
non-leaching (substrate-bound) antimicrobial agents to resist the growth of microbes under
dynamic contact conditions.21
In this work the bacterial inoculum was adjusted to 0.5 McFarland turbidity standard (which
corresponds to a concentration of 1.5–3.0 x 108 CFU/mL) using sterilized Ringer solution. The
concentration of the bacteria dilutions were measured spectrophotometrically by determining the
absorbance at 625 nm. This solution was then diluted in a sterile buffer of 0.3 mM KH2PO4 (pH
= 7.2 ± 0.1) to reach a concentration of 1.5-3.0 x105 CFU/ml, and used as the working bacterial
dilution employed in the assays. For the determination of bacterial inhibition, a fabric sample
impregnated with the microcapsules with dimensions of 2 cm x 2 cm was introduced to 50 ml of
the working bacterial dilution placed in a sterile 250 ml flask. The flask was then capped and
placed in an orbital stirring bath at 37ºC. After one minute of stirring, 1 ml of the solution was
aseptically collected to determine bacterial concentration by the standard plate counting
technique; which involves using serial dilutions and incorporation in Petri dishes with nutrient
agar.
The obtained value was considered as the bacteria concentration at the initial contact time, t0.
After taking the sample, the flask was returned to the bath immediately and stirred for a further
15 minutes. Then, a new sample of the solution was aseptically collected for bacteria counting.
The results of colony counting were converted to colony forming units per milliliter (CFU/ml)
and used to calculate the percentage of bacterial reduction. Two other flasks, one containing
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untreated fabric sample (without microcapsules), and another flask containing only the working
bacterial dilution (without sample addition), both submitted to the same procedure of colony
counting and percentage of bacteria reduction determination, were used as control.
After the first 15 minutes of testing, the inoculum solution of the treated fabric samples and the
blank control was renewed and the sampling was repeated for bacteria counting at 30, 45, 60, 75,
90, 105 and 120 minute time periods. Each time before renewing the inoculum solution of the
fabric sample, the sample was washed thoroughly with sterile deionized water before being
introduced into the fresh inoculum solution. It is noteworthy to mention that the step of the
inoculum renovation (every 15 minutes) is a modification of the original E 2149-01 standard
method, and was introduced by Fernandes et al.,22 to evaluate the effective antibacterial activity
for immobilized antimicrobials on leather coatings. Using a fresh bacterial inoculum at given
specific contact times gives a better idea about the real amount of inhibition after that time of
exposure.22 The percent of bacterial reduction upon contact with the fabric samples was
calculated using the following equation:21
Reduction (%) = (A−B∕A) × 100

(6.2)

where B is the CFU/ml for the flask containing the treated fabric sample after the specified
contact time and A is the CFU/ml for the flask containing the inoculum before the addition of the
treated fabric.

6.3. Results and discussion
6.3.1. Characterization of the produced microcapsules
6.3.1.1. Optical microscopy
The micrographs of the optical microscopy revealed that all the microcapsules were spherical in
shape. The images of formulations 4, 6 and 8 were included in the preceding chapter, section
(5.3.1), with sample codes D, C and F, respectively. The optical microscope images of
formulations 1, 2, 3, 5, 7 and 9 are shown in Figure 6.3, 6.4, 6.5, 6.6, 6.7 and 6.8, respectively.
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Figure 6.3 Optical microscope images of formulation 1. Magnification: a) 400 x and b) 1000 x.

Figure 6.4 Optical microscope images of formulation 2. Magnification: a) 400 x and b) 1000 x.
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Figure 6.5 Optical microscope images of limonene microcapsules of formulation 3.
Magnification: a) 400 x and b) 1000 x.
6.3.1.2. Particle size evaluation
The differential and cumulative particle size distribution (relative to both the total volume and
number of the microcapsules) of the nine formulations was investigated using laser particle size
analyzer. The mean size of the microcapsules of the 9 formulations is shown in Table 6.4.
As it was mentioned in the previous chapters, the type of the emulsifier has an influence on the
size of the produced microcapsules. It can be observed that the use of the emulsifier Tween 20
with sodium tripolyphosphate as hardening agent, resulted in the production of microcapsules
with the smallest mean diameters, regardless of the amount of the oil or wall material used. It
could be also noticed that for the same amount and type of core material; limonene formulations
4 and 6, and vanillin formulations 7 and 9, PGPR emulsifier produced microcapsules with larger
average size than Span 85.
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Figure 6.6 Optical microscope images of limonene microcapsules of formulation 5; produced by
PGPR emulsifier. Magnification: a) 100 x and b) 200 x.

Figure 6.7 Optical microscope images of vanillin microcapsules of formulation 7; (a) after
hardening (b) before hardening. Magnification: a) 200 x and b) 400 x.
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Figure 6.8 Optical microscope images of vanillin microcapsules of formulation 9 produced by
Span 85 emulsifier. Magnification: a) 400 x and b) 1000 x.
Table 6.4 Mean diameters per volume of microcapsules, EE %, solid content
emulsifier used in each formulation.
Mean
particle
size
Formulation
Type of Emulsifier
diameter
EE%
(µm)
1
Tween 20
11.2
64.2%
2
Tween 20
3.9
92.3%
3
Tween 20
8.0
98.4%
4
PGPR
18.4
90.4%
5
PGPR
39.0
94.1%
6
Span 85
11.1
98.6%
7
PGPR
15.7
95.7%
8
PGPR
38.3
98.3%
9
Span 85
10.4
100 %

% and the
Solid
Content
%
6.1
24.9
20.4
27.8
28.8
25.3
28.3
29.7
25.4

The size distribution charts for all the studied formulations are included in the Appendix of this
chapter, except for formulations 3, 4, 8 and 6 which were formerly presented in chapter 5.
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6.3.1.3. Encapsulation efficiency of microcapsules
The percentage of the encapsulated core material in each formulation is reported in Table 6.4.
The vales of EE% ranged from 64.2% to100%. This variation was discussed before in detail in
chapter 4.
6.3.1.4. Effect of heat on the morphology of microcapsules
Limonene microcapsules resulting from formulations 3, 4, 5 and 6 were all subjected to
temperatures of 50ºC, 120ºC, and 160ºC for 5, 2 and 2 minutes, respectively. The optical
microscope images of the remaining microcapsules (microcapsules not destroyed during the
heating process) revealed that the highest decline in the number of the microcapsules was
observed for formulations 3 and 5 (Figure 6.9 (a) and (c)). It was also observed that the
multinuclear microcapsules of formulation 5 maintained their morphology in spite of their
decreased number, unlike the microcapsules of formulation 4 which did not retain the
multinuclear morphology after the thermal treatment but did not show significant decrease in
number. This may be due to the higher amount of the emulsifier PGPR and limonene in
formulation 5, in comparison with formulation 4, helped the microcapsules to maintain their
original structural features.
6.3.1.5. Solid content
The solid content of the formulations was determined prior to the grafting process and without
washing the microcapsules according to the procedure described in chapter 3 (Section 3.2.2.6).
The values extended from 6.1% to 29.7% as shown in Table 4. It was found that the
microcapsules prepared with tannic acid as the hardening agent had higher solid content % than
the ones hardened with sodium tripolyphosphate. Furthermore, it was noticed that microcapsules
prepared with the emulsifier PGPR and hardened with tannic acid had a higher solid content %
than those produced with Span 85, using the same hardening agent.

113

6.3.2. Characterization of the treated fabrics
6.3.2.1. Simple coating method
In this procedure the microcapsules were not chemically fixed onto the fabrics, but rather applied
by immersing the fabric in the microcapsules suspension and allowing it to be air-dried. These
physically attached microcapsules would not be retained if the fabric is washed.19 However, this
method might be suitable for disposable fabrics, such as surgical clothing and gowns and some
other healthcare textiles that would not need to be washed and thus, no chemical reaction is
needed to fix the microcapsules onto the fabric. SEM images of the surface of cotton fabrics
treated with vanillin microcapsules of formulation 1 by this method are shown in Figure 6.10.
The SEM images reveal that the deposited microcapsules have spherical shape and rough surface
and were found mostly in aggregates positioned in the spaces present between the fabric fibers.

Figure 6.9 Optical microscope images of limonene microcapsules, after exposure to
temperatures of 50ºC, 120ºC, and 160º C for 5, 2, and 2 minutes, successively. (a) Formulation 3,
(b) Formulation 4, (c) Formulation 5 and (d) Formulation 6.
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Figure 6.10 SEM images of cotton fabrics with vanillin microcapsules of formulation 1 applied
with simple coating method.
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The elemental analysis of the wall material composition of the vanillin microcapsules deposited
on the fabrics with quantification is presented in Figure 6.11. The presence of carbon, nitrogen
and oxygen with percentages similar to the originally present in the structure of gum Arabic and
chitosan was detected, which confirms the presence of both polymers in the shell of the
microcapsules.

Figure 6.11 Results of the elemental analysis of the wall material composition of the
microcapsules on the treated fabrics (obtained by SEM).
6.3.2.2. Fixation of microcapsules with Baypret USV® binder
Baypret USV® is a polymeric binder based on polyether polyurethane that is frequently used to
immobilize the microcapsules on the fabrics. It could be observed from the SEM images (Figure
6.12) of the fabrics impregnated with vanillin microcapsules of formulations 1 and 2 by using
this polymeric binder that the morphological features of the microcapsules were significantly
vanished becoming completely covered with a thick film of the binder. The drawbacks of using
polymeric binders, as reported in the literature, include the change of the textiles properties, such
as the decrease of the air permeability and breathability, softness, increased fabric drape, and
change in the tensile strength.23
However, the use of polyurethane binders to successfully bind microcapsules to textiles
substrates has been reported, such as the example of polyurethane-urea microcapsules1,16 and
melamine–formaldehyde microcapsules.23 Since it has been also reported that the fixation of the
microcapsules with a polymeric binder depends on the chemical nature of the microcapsules, as
well as the textile substrates,23 in this context, we can conclude that polyurethane binder is most
likely inadequate to be used with the microcapsules wall materials and/or the fabric used in this
study.
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(a)

(b)

(c)

Figure 6.12 SEM micrographs of cotton fabrics impregnated with vanillin microcapsules and
Baypret USV® binder: (a) Formulation 1 (b) Formulation 2 (c) Control fabric.
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6.3.2.3. Grafting with citric acid and thermofixation
Cotton fabrics impregnated with microcapsules of different formulations and grafted thermally
with citric acid were examined with SEM. It was observed that only small amount of the
limonene microcapsules of formulation 3, the one prepared with Tween 20 emulsifier and
hardened with sodium tripolyphosphate could be grafted onto the fabrics by drying at 90ºC for 2
min and curing at 120ºC for 3 min (Figure 6.13). The grafted microcapsules of this formulation
were spherical in shape and some had a noticeable rough surface. A very similar observation was
reported by Butstraen et al.,24 who encapsulated Miglyol by chitosan and gum Arabic using
sodium tripolyphosphate as the hardening agent. Butstraen et al reported that the rough surface
of the shell consisted of smaller coacervated particles. Apparently, this rough surface is a result
of using sodium tripolyphosphate as the hardening agent; since the surface of the microcapsules
has become smooth when tannic acid was used to harden the microcapsules instead of sodium
tripolyphosphate, as presented in the succeeding sections. The small number of grafted
microcapsules could be due to the thermal instability of the microcapsules and their inability to
tolerate the high temperature of the treatment.
Fabrics impregnated with formulations 6 and 9 that were produced with Span 85 emulsifier did
not have any attached microcapsules after the drying and curing step. However, some remnants
of the microcapsules could be observed in spaces between the fabric fibers as shown in Figure
6.14. This suggests that the formulations obtained from Span 85 emulsifier could not survive the
conditions of the thermofixation and curing at 120ºC.
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Figure 6.13 Limonene microcapsules of formulation 3 grafted on cotton fabrics by chemical
grafting method followed by drying at 90ºC and curing at 120ºC. Grafting was done by citric
acid and sodium phosphate monobasic monohydrate as a catalyst.
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(a)

(b)

Figure 6.14 SEM images of fabrics impregnated with (a) limonene microcapsules of formulation
6 and (b) vanillin microcapsules of formulation 9. Both formulations could not sustain the
treatment and remnants of microcapsules could be observed.
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SEM images of the fabrics treated with limonene and vanillin microcapsules obtained from
formulations 4 and 7 are shown in Figure 6.15 and 6.16, respectively. Despite the fact that the
two formulations were prepared with the same amounts of PGPR emulsifier (0.35 g) and the
hardening agent tannic acid, and undergone the same conditions of drying at 90ºC and curing at
120ºC, it could be observed that higher number of vanillin microcapsules could be grafted
(Figure 6.16) than the limonene ones (Figure 6.15). This suggests that the type of the core
material may have an influence on the stability and thus, on the amount of the grafted
microcapsules; since the two formulations experienced the same conditions during the
preparation and grafting and contained the same amounts and types of all the ingredients, except
for the encapsulated core. Taking into consideration that the vanillin was dissolved in corn oil, it
might have helped in keeping the integrity of the microcapsules during the treatment more than
the other formulation in which the core phase was limonene itself.
It was also observed that the grafted microcapsules in the both formulations seemed to be
covered with a thin film-like layer. This film was considerably less evident when the curing
temperature was elevated to 150ºC for 2 minutes. SEM micrographs of grafted vanillin
microcapsules of formulation 7 (Figure 6.17) show that the microcapsules have become more
visible than the grafted vanillin microcapsules (Figure 6.16) after raising the curing temperature
of the samples to 150ºC.
The highest amount of microcapsules that was successfully grafted onto the fabrics resulted from
the limonene microcapsules of formulation 5 (Figure 6.18 and 6.19) and vanillin microcapsules
of formulation 8 (Figure 6.20) using a curing temperature of 120ºC for 3 minutes. This is
probably because of their relatively higher solid content (w/w %) when compared with the other
formulations, as shown in Table 6.4 (Formulation 5= 28.8%; Formulation 8= 29.7%). Perhaps
the high amount of PGPR and the presence of tannic acid as the hardening agent resulted in
improved thermal stability of the microcapsules during the thermofixation and curing steps. It
was also noticed that the increasing of the amount of emulsifier to 0.6 g, together with increasing
the amount of core (limonene oil and vanillin dissolved in corn oil) made the limonene
formulation endure the treatment better than the one with vanillin; on the contrary to what was
observed previously in formulations 4 and 7 with lower core and emulsifier amounts, where the
vanillin formulation was more stable than that with limonene. The impact was obvious in the
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amount and distribution of the fixed microcapsules. The film that covered the microcapsules in
the previous formulations did not appear in this case, revealing the smooth appearance of the
microcapsules surface, although the curing was performed at the same temperature.
Compared with the mean average size of microcapsules in both formulation 5 and 8 (39.0µm
and 38.3µm, respectively), it was observed that only microcapsules of smaller diameter could be
grafted and retained on the textiles after curing. This is perhaps due to the removal of the bigger
microcapsules in the washing step that was performed directly after the reaction with citric acid
and before the thermofixation process. Monllor et al. reported a similar observation and
concluded that the smaller microcapsules tend to remain on the fabrics after several washing
cycles, whereas the larger ones are usually lost faster.25
Interestingly, the optical microscope images of fabrics impregnated with these two formulations
indicated that the microcapsules seemingly kept their polynuclear morphology of their internal
phase after the thermal fixation and curing reaction at 120ºC (Figure 6.21).
Figure 6.22 shows that increasing the curing temperature applied to limonene microcapsules of
formulation 5 to 150ºC resulted in lowering the number of the grafted limonene microcapsules.
Accordingly, it can be concluded that curing at 120ºC for 3 minutes was more favorable for this
formulation.
6.3.2.4. Effect of washing
SEM images of fabrics impregnated with limonene microcapsules of formulation 5 that was
subjected to a washing process with commercial soap and acid, process repeated for three times
according to the method described previously in Section 6.2.4.4, are shown in Figure 6.23. It can
be seen that the acidic washing solution affected the appearance of the fabrics; nevertheless, it
showed that the microcapsules are still firmly attached onto them.
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Figure 6.15 SEM images of fabrics impregnated with limonene microcapsules of formulation 4
cured at 120ºC.
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Figure 6.16 SEM images of fabrics impregnated with vanillin microcapsules of formulation 7
cured at 120ºC for 3 minutes.
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Figure 6.17 SEM images of fabrics impregnated with vanillin microcapsules of formulation 7
cured at 150ºC for 2 minutes.
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Figure 6.18 SEM images of fabrics impregnated with limonene microcapsules of formulation 5
cured at 120ºC for 3 minutes.
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Figure 6.19 SEM images of fabrics impregnated with limonene microcapsules of formulation 5
cured at 120ºC for 3 minutes.

127

Figure 6.20 Vanillin microcapsules of formulation 8 grafted on cotton fabrics by chemical
grafting method followed by thermal drying and curing at 120ºC for 3 minutes.
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(b)

(a)

Figure 6.21 Optical microscope images of (a) limonene microcapsules of formulation 5 and (b)
vanillin microcapsules of formulation 8, grafted on cotton fabrics by chemical grafting method
followed by thermal drying and curing at 120ºC for 3 minutes.
6.3.2.5. Fixation with citric acid and microwave
Using the microwave technology to adhere and cure the microcapsules seemed to be destructive,
since the SEM images of fabrics impregnated with formulation 5 and 8 and treated with the
microwave for one minute showed almost no microcapsules except few scattered ones which are
oval in shape (Figure 6.24). This perhaps suggests that the curing time or/and the microwave
power level should have been decreased to avoid the loss of the microcapsules or that this
method is not suitable for these formulations.
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Figure 6.22 SEM images of fabrics impregnated with limonene microcapsules of formulation 5
cured at 150ºC for 2 minutes.
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Figure 6.23 SEM micrographs of cotton fabrics impregnated with limonene microcapsules
(formulation 5) after being washed with 2% commercial soap and 0.1N acetic acid.
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Figure 6.24 SEM images of fabrics impregnated with (a) limonene microcapsules of formulation
5 and (b) vanillin microcapsules of formulation 8; both cured using a home-use microwave.
6.3.2.6. FTIR Spectra
The FTIR spectra of tannic acid (the hardening agent), the freeze-dried limonene microcapsules
(formulation 5), citric acid (the cross-linker), control cotton fabric, and the treated cotton fabric
(with formulation 5, cured at 120ºC for 3 minutes) are shown in Figure 6.25. The FTIR spectrum
of tannic acid (Figure 6.25.A) showed a broad band from about 3000 cm-1 to 3350 cm-1 centered
at 3326 cm-1; which represents the stretching vibrations of –OH groups in the phenolic structure
of tannic acid.26 The two sharp peaks present at 1698 cm-1 and 1607 cm-1 can be assigned to the
C=O group stretching and the aromatic C-O stretching vibrations, respectively. Similar
characteristic sharp peaks for tannic acid are reported at 1713 cm-1and 1613 cm-1 in the
literature.26,27
The spectrum of the chitosan/gum Arabic microcapsules loaded with limonene (Figure 6.25.B)
showed the presence of an important peak at 2855 cm-1. This same peak was reported in the
literature as an indication of the occurrence of complex coacervation between chitosan and gum
Arabic; and it was also reported that such peak does not appear in the individual FTIR spectra of
chitosan and gum Arabic.28 Additionally, the broad band at about 3300 cm-1 is attributed to the –
OH groups of both chitosan and gum Arabic along with the overlapping stretching band of the –
NH of chitosan. This band can also represent the hydrogen bonds established between gum
Arabic and chitosan.24 It can also reflect the hydrogen bonding with tannic acid that was used as
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the hardening agent; as a similar broad band was seen in its individual spectrum as previously
mentioned. The peak that appears at 1731 cm-1 indicates the chemical combination between
chitosan and gum Arabic that formed the shell of the microcapsules; since a similar peak (at
1720 cm-1) was reported by Yang et al.28 The peak appearing at 2924 cm-1 is due to C-H
stretching vibration, while the one present at 1610 cm-1 is related to chitosan structure and
represents –NH angular deformation.24
The spectrum of citric acid (Figure 6.25.C) has shown peaks of stretching vibrations absorption
of –OH groups at about 3492 cm-1 and 3280 cm-1. The two peaks of strong intensity which
appeared at 1742 cm-1 and 1693 cm-1 represent the characteristic stretching C=O of the -COOH
group of acids. These values are very close to those reported by Yang et al.10
The FTIR spectrum of the untreated (control) cotton fabric sample (Figure 6.25.D) has shown
peaks at 3332 cm-1, 2899 cm-1 and 1029 cm-1 that correspond to the stretching vibrations of the
groups –OH, -CH and –C-O-C- present in the cellulosic structure of cotton, respectively.10,19
The peak that appears at 1645 cm-1 is probably due to the presence of interstitial water in the
cellulosic structure.29
The spectrum of cotton fabric impregnated with limonene microcapsules (Figure 6.25.E) has
shown the disappearance of the sharp peaks at 1742 cm-1 and 1693 cm-1 that previously appeared
in the spectrum of the cross-linker citric acid, which indicates that they had become involved in
bonding, i.e., the esterification reaction between the carboxylic group of citric acid and the –OH
group of the cotton cellulose.10 The spectrum also revealed the appearance of a new peak of C=O
ester stretching at 1729 cm-1, which was not present in the control cotton fabric sample. This
peak confirms the covalent attachment between the polymeric shell of the microcapsules (of
chitosan and gum Arabic) and cotton cellulose via citric acid through ester bond formation. 12
Additionally, the presence of a peak at 1637 cm-1 with small intensity, which is assigned to the
bending vibration of the –NH group, points out to the chemical reaction between the residual free
–NH2 groups of chitosan in the microcapsules shells and the –COOH groups of citric acid.10
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Figure 6.25 FTIR spectra of: A) tannic acid; B) microcapsules; C) citric acid; D) untreated
cotton fabric and E) cotton fabric treated with microcapsules.
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6.3.3. Antibacterial activity
6.3.3.1. Agar diffusion
This assay was conducted to investigate the antibacterial activity of the free microcapsules
before being grafted onto the fabrics. Figures 6.26 and 6.27 show the results of the agar diffusion
assay for different formulations of limonene and vanillin, respectively. The results indicated that
all the formulations exhibited bacterial growth inhibition against both S. aureus and E.coli. Table
6.5 lists the values of the measured diameters of the inhibition zones of the formulations after
incubating the plates for 24 hours and for 4 days, the assay was performed in duplicate for each
sample. Since the antibacterial effect of chitosan mainly depends on the presence of its positively
charged amino groups freely to interact with the negative charges of the bacterial wall,30 it is
important to mention that the antibacterial effect exhibited by the microcapsules is
predominantly due to the encapsulated vanillin and limonene during their release trough the
microcapsules wall (chitosan and gum Arabic), and not from the chitosan itself. This is because
during the microcapsules preparation process by the complex coacervation method most of the
positively amino groups of chitosan have been complexed with negative carboxylic groups of the
gum Arabic to form the shell of the microcapsules.
The higher initial antibacterial effect that was exhibited by the non-encapsulated limonene oil
dissolved in DMSO, and manifested in the bigger zone of inhibition (as shown in Table 6.5)
might be related to the antibacterial activity of DMSO along with the limonene.31 Furthermore, it
has been observed for the previously obtained inhibition zones, that after 4 days of incubation,
they have become covered with bacteria. In contrast, the bacterial effect of the encapsulated oil
was maintained after 4 days of incubation under the same conditions. This sustainable
antibacterial effect of the encapsulated limonene and vanillin in the examined microcapsules
formulations is acquired as a result of the achieved controlled release (previously investigated in
chapter 5), and demonstrates the enhanced stability and prolonged antibacterial effect of the
encapsulated core materials, which would extend the potential use of vanillin and limonene
microcapsules in different applications.
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Table 6.5 Average diameters of inhibition zones (cm) of limonene and vanillin microcapsules
suspensions and free oils in the plate test with E. coli and S. aureus.
E.coli
S. aureus
After
24 After
4 After
24 After 4 days
Formulation/Sample
hours
of days
of hours
of of
incubation
incubation
incubation
incubation
1.25±0.080

1.50±0.133

1.50±0.133

5

1.5±0.000

1.5±0.000

1.45±0.069

1.45±0.069

6

1.25±0.400

1.25±0.400

1.35±0.074

1.35±0.074

7

1.45±0.207

1.45±0.207

1.45±0.069

1.45±0.069

8

1.50±0.000

1.55±0.065

1.50±0.000

1.55±0.065

9

0.80±0.000

1.20±000

1.55±0.065

1.55±0.065

Limonene oil/DMSO

3.30±0.303

- (*)

3.30±0.181

- (*)

Vanillin /corn oil

0.95±0.316

- (*)

1.00±0.200

- (*)

Vanillin

Limonene

1.25±0.080

Core material

4

- (*) After 4 days of incubation, the bacteria grown up in the inhibition zone initially formed.
6.3.3.2. Standard test method under dynamic contact conditions
This assay was conducted on cotton fabrics impregnated with limonene microcapsules of
formulation 5 and vanillin microcapsules of formulation 8 (cured at 120º C for 3 minutes); as
they gave good grafting outcome .The assay was performed after washing the samples by the
method previously described in Section 6.2.4.4. The results of the assay for formulation 5 and 8
are shown in Table 6.6 and Table 6.7, respectively.
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Figure 6.26 Zone of inhibitions of limonene microcapsules of formulations: a (4), b (5) and c (6)
against S. aureus, and of formulations: d (4), e (5) and f (6) against E.coli after 24 hours of
incubation.

Figure 6.27 Zone of inhibitions of vanillin microcapsules of formulations: a (7), b (8) and c (9)
against S. aureus, and of formulations: d (7), e (8) and f (9) against E.coli after 24 hours of
incubation.
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Table 6.6 Results of the bacterial reduction % in the dynamic test of the fabric impregnated with
limonene microcapsules formulation 5.
Sample
Time
(minutes)

Number
of
of
Number
of Number
bacteria – sample Bacterial
bacteria
– bacteria – control (fabric
with reduction *
(fabric without
inoculum
limonene
(%)
microcapsules)
solution
microcapsules)
(CFU/ml) (A)
(CFU/ml)
(CFU/ml) (B)

0

3.00x105

3.00x105

1.50x104

49.00

15

3.00x105

2.50x105

1.24x104

95.90

30

3.00x105

2.96x105

1.42x104

52.72

45

3.00x105

2.81x105

1.69x104

43.70

60

3.00x105

2.94x105

1.91x104

36.33

75

2.98x105

2.96x105

1.91x104

35.92

90

2.90x105

2.86x105

1.93x104

33.44

105

3.00x105

2.88x105

2.20x104

33.03

120

3.00x105

3.00x105

2.20x104

26.72

(*) – reduction of the bacteria number = (A-B)/A*100
It can be observed, that both fabric samples exhibited an antibacterial activity against E. coli,
whereby the fabric treated with limonene microcapsules showed 95.90% of bacterial reduction
and the one impregnated with vanillin microcapsules showed 98.17 % after 15 minutes of
contact. A bacteriostatic activity is generally regarded if a reduction percentage between 90%
and 99.9% of the total bacteria count (CFU/mL) in the original inoculum is obtained.22 As was
mentioned previously, this assay involved the renewal of the bacterial inoculum at each
sampling. In other words, every 15 minutes the fabric sample was withdrawn, washed thoroughly
with sterilized water and placed in contact with a new/fresh bacterial inoculum in order to take
samples for colony counting. It is obvious from the results obtained that although the bacterial
reduction percentage decreased with time, nevertheless, it was maintained throughout the 8
renewal cycles for both fabric samples, which is consistent with a gradual release and a long
lasting effect.
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Table 6.7 Results of the bacterial reduction % in the dynamic test of the fabric impregnated with
vanillin microcapsules of formulation 8.
Sample
Time
(minutes)

Number
of
bacteria
–
inoculum
solution
(CFU/ml) (A)

Number
of
Number
of
bacteria – sample Bacterial
bacteria – control
(fabric
with reduction *
(fabric without
vanillin
(%)
microcapsules)
microcapsules)
(CFU/ml)
(CFU/ml) (B)

0

3.00x105

2.94x105

1.34x104

55.30

15

3.00x105

2.74x105

5.50x102

98.17

30

2.50x105

2.69x105

1.41x104

43.60

45

2.45x105

2.93x105

1.58x104

35.51

60

2.36x105

2.95x105

1.54x104

34.80

75

2.71x105

2.94x105

1.88x104

30.63

90

2.82x105

2.92x105

1.98x104

29.80

105

2.78x105

2.94x105

1.96x104

29.50

120

2.60x105

2.96x105

1.99x104

23.46

(*) – reduction of the bacteria number = (A-B)/A*100

6.4. Conclusion
In this chapter, the possibility of imparting a durable antimicrobial finish to cotton fabrics by the
impregnation of the limonene and vanillin microcapsules was successfully achieved using green
and non-toxic materials. Nine formulations of microcapsules and several methods for their
grafting onto the cotton fabrics were investigated. Considering the optimum fixation conditions,
it was found that the use of citric acid as a polycarboxylic acid cross-linker followed by the
thermofixation and thermal curing (at 120ºC) provided higher yield of attached microcapsules
without affecting their morphology.
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Appendix 6. Particle size distribution charts of the formulations investigated in Chapter
6

(a)

(b)
Figure 6.A Particle size distribution of vanillin microcapsules of formulation 1; (a) distribution
in volume (b) in number.
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(a)

(b)
Figure 6.B Particle size distribution of vanillin microcapsules of formulation 2; (a) distribution
in volume (b) in number.
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(a)

(b)

Figure 6.C Particle size distribution of limonene microcapsules of formulation 5; (a) distribution
in volume (b) in number.
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(a)

(b)
Figure 6.D Particle size distribution of vanillin microcapsules of formulation 7; (a) distribution
in volume (b) in number.
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(a)

(b)
Figure 6.E Particle size distribution of vanillin microcapsules of formulation 9; (a) distribution
in volume (b) in number.
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Chapter 7: General Conclusions and Future Prospects
In light of the proposed objectives and the obtained results of this thesis project, it could be
concluded that the production of microcapsules with fragrant and antimicrobial properties and
their application onto textile substrate using eco-friendly materials was successfully achieved.
In summary, the main findings of the work are:
-

The production of limonene and vanillin microcapsules was accomplished by means of
the complex coacervation using gum Arabic and chitosan as shell materials and green
hardening agents (tannic acid and sodium TPP). To our knowledge, this is the first
successful encapsulation of the cargo using this method; as the available literature on
complex coacervation to date did not refer to the encapsulation of limonene and vanillin
(in pure form and not vanilla oil) by the usage of chitosan and gum Arabic as the wall
material pair.

-

The type of the emulsifier used in the microcapsule preparation was found to have a
significant influence on their size, morphology (being mononuclear or polynuclear), EE%
and the release pattern of the core material through the wall.

-

The encapsulation efficiencies of the prepared microcapsule formulations was determined
by GC-FID and ranged between 62% and 100% and the values highly depended on the
emulsifier used. Span 85 emulsifier resulted in the highest EE %.

-

The release profile was affected by the concentration of the used biopolymers, type of
core material and the morphology of the microcapsules. Increasing the amount of
polymeric wall materials resulted in slower release rate. Additionally, it was found that
lower amount of vanillin than limonene was released over the same release duration and
conditions. This might be related to the lower volatility and also diffusivity of the former.
It was also noted that the limonene multinuclear microcapsules demonstrated slower
release rate than the mononuclear ones.

-

Among all the different formulations that were prepared, it was confirmed by SEM and
FTIR that the multinuclear limonene and vanillin microcapsules obtained by the PGPR
emulsifier and hardened with tannic acid are the ones that tolerated the thermofixation
conditions and were successfully grafted on the cotton fabrics by citric acid. This
highlights the fact that some formulations, regardless of their high EE% and uniform
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release profiles were not suitable for the grafting reaction and could not survive its high
temperature.
-

The antibacterial assays of both the free microcapsules and the treated cotton fabrics have
shown that they exhibited a sustained antibacterial activity. The average diameters of the
inhibition zones of the agar diffusion tests ranged between 0.8-1.5 cm against E. coli, and
1.35-1.55 cm against S. aureus, and did not show a significant increase after being
incubated for 4 days. However, this inhibitory effect of the microcapsules was
maintained, unlike the non-encapsulated limonene and vanillin, which displayed bacterial
growth in the inhibition zones that were initially formed; indicating un-sustained bacterial
inhibition. The cotton fabrics impregnated with limonene and vanillin microcapsules
have shown 95.9 % and 98.2 % of bacterial reduction after 15 minutes of exposure,
respectively. This percentage significantly decreased but the bacterial reduction was
maintained to more than 20% after 8 renewable cycles of the bacterial inoculum.

Suggestions for future research:
-

It is recommended that future work on the impregnated fabrics produced here would
focus on the washing durability and maintaining the fragrant and the antimicrobial effect
of the treated fabrics after several washing cycles. This would in turn promote the
extension of the production to a large scale.

-

Another important area for future research is working on narrowing the size distribution
of the produced microcapsules; as this is expected to affect the release behavior and
uniformity of the grafted microcapsules.

-

It is also important in the next step to study the release of the active agents from the
microcapsules after being fixed on the fabrics. This would help in determining whether
the fixed microcapsules would maintain the same release profiles as the free ones or the
grafting affects their release pattern.

-

More investigations are needed to be conducted on the formulations of vanillin and
limonene microcapsules that were produced by Span 85 emulsifier and have shown the
highest EE% (ranging between 98.6% and 100 %) but failed to be grafted on cotton
fabrics by citric acid. These microcapsules exhibited a controlled release profile and
sustained antibacterial activity against S. aureus and E. coli. Therefore, it is desirable to
study their fixation on the fabrics by other means or their incorporation in other possible
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applications, such as cosmetics or food products that do not need high processing
temperature range.
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